Select Page

Posts Table Barn2 Test

DateCompanyStock TickerTitleCategoryDownload Linkdlm_download_category_hfilter
01-26-2023Aurinia Pharmaceuticals Inc.NASDAQ:AUPHOne Day….Two Positive IP Events.BiotechnologyDownloadbiotechnology
01-18-2023Miravo HealthcareTSX:MRVA Fair Take-out Valuation.Specialty PharmaceuticalDownloadspecialty-pharmaceutical
01-18-2023Neovasc Inc.NASDAQ:NVCN; TSX:NVCNVery Honorable.Medical TechnologyDownloadmedical-technology
01-11-2023Reunion Neuroscience Inc.NASDAQ:REUN; TSX:REUNPhase 1 Supports Target Product Profile.BiotechnologyDownloadbiotechnology
01-04-2023Aurinia Pharmaceuticals Inc.NASDAQ:AUPHNice Sunset(tlement)BiotechnologyDownloadbiotechnology
12-23-2022Microbix Biosystems Inc. TSX:MBXDisappointing 4Q-2022 Results and More Cautious Near-Term OutlookDiagnosticsDownloaddiagnostics
12-20-2022Zymeworks Inc.NASDAQ:ZYMETop-Line HERIZON-BTC-01 Results PositiveBiotechnologyDownloadbiotechnology
12-19-2022Top Ideas2023 Top IdeasSector ReportsDownloadsector-reports
12-12-2022Zymeworks Inc.NASDAQ:ZYMECombo Efficacy a Bit Lower; Still CompetitiveBiotechnologyDownloadbiotechnology
12-06-2022CareRx Corp.TSX-CRRXCritical Mass in Place, Looks Primed for Sustained GrowthHealthcare ServicesDownloadhealthcare-services
12-05-2022Mimi’s Rock Corp.TSX-V:MIMIAcquisition by FitLife BrandsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-28-2022Reunion Neuroscience Inc.NASDAQ:REUN; TSX:REUN, Reunion Coverage Transition: Continue to Have ‘High’ Expectations.BiotechnologyDownloadbiotechnology
11-23-2022Hamilton Thorne Ltd.TSX-V:HTL3Q-2022 Results Mixed.Healthcare ServicesDownloadhealthcare-services
11-17-2022BioSyent Inc.TSX-V:RX3Q-2022 Results: New Launches Slow but Gathering SteamSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-16-2022CloudMD Software & Services Inc.TSX-V:DOC3Q-2022 Results Miss but Improving Margins and Pipeline PromisingDigital HealthDownloaddigital-health
11-16-2022Miravo HealthcareTSX:MRV3Q-2022 Results Beat. Remaining on Sidelines Due to Patent Cliffs and Debt.Specialty PharmaceuticalDownloadspecialty-pharmaceutical
11-11-2022Knight Therapeutics Inc. TSX: GUD3Q-2022 Financial Results.Specialty PharmaceuticalDownloadspecialty-pharmaceutical
11-10-2022HLS Therapeutics Inc. TSX: HLS3Q-2022 Results Mixed – Is That an Inflection we See on the Horizon?Specialty PharmaceuticalDownloadspecialty-pharmaceutical
11-10-2022Medexus Pharmaceuticals Inc. TSX:MDP2Q-2023 Results – Strong U.S. Sales Drive OutperformanceSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-10-2022Greenbrook TMS Inc.NASDAQ:GBNH; TSX-GTMS3Q-2022 Results Mixed – Strong Top Line with Synergies ForecastHealthcare ServicesDownloadhealthcare-services
11-09-2022AbCellera Biologics Inc.NASDAQ:ABCL3Q-2022 Results: Bebtelovimab Runs its Course; Program Starts Slow, but Downstream Participation Increases.BiotechnologyDownloadbiotechnology
11-09-2022Mimi’s Rock Corp. TSX-V:MIMI3Q-2022 Results In Line.Specialty PharmaceuticalDownloadspecialty-pharmaceutical
11-04-2022Chinook Therapeutics Inc.NASDAQ:KDNYASN Data: Class-Leading Profiles Further Validated.BiotechnologyDownloadbiotechnology
11-03-2022Aurinia Pharmaceuticals Inc.NASDAQ:AUPH3Q-2022 Lupkynis Sales Miss. Guidance Cut (2022)/Low (2023) – Back to School.BiotechnologyDownloadbiotechnology
11-03-2022Viemed Healthcare Inc.NASDAQ-VMD; TSX-VMD;3Q-2022 Results – Early Signs of Margin ExpansionHealthcare ServicesDownloadhealthcare-services
10-31-2022ESSA Pharma Inc.NASDAQ:EPIXNever a Straight Line – Janssen Suspension of Enrollment Likely Just a Speed Bump We Believe.BiotechnologyDownloadbiotechnology
10-26-2022ESSA Pharma Inc.NASDAQ:EPIXBack on Track – Initial Combo Efficacy Results Beat Benchmark and Support EPI-7386 Biology.BiotechnologyDownloadbiotechnology
10-24-2022Zymeworks Inc. NYSE:ZYMEBusy Week Changes Investment Thesis – More Risk; More (Potential) Reward.BiotechnologyDownloadbiotechnology
10-17-2022Chinook Therapeutics Inc. NASDAQ:KDNYTravere’s Regulatory Setback and ASN Abstracts.BiotechnologyDownloadbiotechnology
09-29-2022Medicenna Therapeutics Corp.NASDAQ:MDNA; TSX:MDNAABILITY Update Mixed. Emerging MDNA11 Profile Remains Positive – Continues to Support an Undervaluation Thesis.BiotechnologyDownloadbiotechnology
09-20-2022Medexus Pharmaceuticals Inc. TSX:MDPTreosulfan Delayed Again; Downgrading to SellSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-24-2022BioSyent Inc. TSX-V:RX2Q-2022 Results Miss Due to Channel Inventory AdjustmentSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-24-2022CloudMD Software & Services Inc.TSX-V:DOC2Q-2022 Results Miss; Downgrading on Growth and Balance Sheet ConcernsDigital HealthDownloaddigital-health
08-24-2022Hamilton Thorne Ltd. TSX-V:HTL2Q-2022 Review. Performing Well in a FX- and Supply Chain-Challenged EnvironmentHealthcare ServicesDownloadhealthcare-services
08-16-2022Mimi’s Rock Corp. TSX-V:MIMIStrong 2Q-2022 Results and Improved OutlookSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-16-2022Miravo Healthcare TSX:MRV2Q-2022 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-16-2022Medicenna Therapeutics Corp. NASDAQ:MDNA; TSX:MDNAIn a Good Place – Financially, Clinically and BiologicallyBiotechnologyDownloadbiotechnology
08-15-2022Knight Therapeutics Inc. TSX:GUD2Q-2022 Results Beat EstimatesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-15-2022HLS Therapeutics Inc. TSX:HLS2Q-2022 Results In Line. Vascepa Growth Estimate Light for Remainder of 2022Specialty PharmaceuticalDownloadspecialty-pharmaceutical
08-12-2022Microbix Biosystems Inc. TSX:MBX3Q-2022 Results In Line and Large QAPs Deal Adds to Future GrowthDiagnosticsDownloaddiagnostics
08-12-2022Neovasc Inc. NASDAQ:NVCN; TSX:NVCN2Q-2022 Results – Green Shoots.Medical TechnologyDownloadmedical-technology
08-12-2022Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.)NASDAQ:REUN; TSX:REUNFocus Turns to FT-104BiotechnologyDownloadbiotechnology
08-11-2022Newtopia Inc. TSX-V:NEWU2Q-2022 Results – Weak Quarter but Pipeline has PotentialDigital HealthDownloaddigital-health
08-11-2022AbCellera Biologics Inc. NASDAQ:ABCL2Q-2022 Results: Cashed Up for Growth.BiotechnologyDownloadbiotechnology
08-10-2022Medexus Pharmaceuticals Inc. TSX-V:MDP1Q-2023 Results – Revenues Beat on U.S. StrengthSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-05-2022Aurinia Pharmaceuticals Inc. NASDAQ:AUPH2Q Lupkynis Sales Beat. PSFs LowBiotechnologyDownloadbiotechnology
08-04-2022Viemed Healthcare Inc.NASDAQ:VMD, TSX:VMD2Q-2022 Results – Core Business Pushing ThroughHealthcare ServicesDownloadhealthcare-services
08-04-2022Greenbrook TMS Inc. NASDAQ:GBNH, TSX:GTMS2Q Impacted by Headwinds which are Easing; Moving Toward a Sweet SpotHealthcare ServicesDownloadhealthcare-services
07-28-2022Medicenna Therapeutics Corp. NASDAQ:MDNA; TSX:MDNAABILITY Update – Incremental; Continues to Point in Right DirectionBiotechnologyDownloadbiotechnology
07-28-2022Aurinia Pharmaceuticals Inc. NASDAQ:AUPHA Jab from PTABBiotechnologyDownloadbiotechnology
07-26-2022HLS Therapeutics Inc. TSX:HLSLargest Province on Board with VascepaSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-25-2022Liminal BioSciences Inc. NASDAQ:LMNLLimited Pipeline Potential and Insufficient Cash Runway to Reach Clinical CatalystsBiotechnologyDownloadbiotechnology
07-15-2022Greenbrook TMS Inc. NASDAQ:GBNH, TSX:GTMSRubber….Meet Road. Closing of Success TMS Acquisition and US$75 Million Credit FacilityHealthcare ServicesDownloadhealthcare-services
07-13-2022Bellus Health Inc. NASDAQ:BLU; TSX: BLUMore Clarity May Bring Suitors CloserBiotechnologyDownloadbiotechnology
07-06-2022Mimi’s Rock Corp. TSX-V:MIMI4Q-2021 and 1Q-2022 Results MissSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-05-2022Neovasc Inc.NASDAQ:NVCN; TSX:NVCNHistorical Challenges Mask Enormous Upside Potential – Tackling Two Gaps in CVD* CareMedical TechnologyDownloadmedical-technology
06-28-2022ESSA Pharma Inc. NASDAQ:EPIXEPI-7386 Phase 1a Update – Mixed ResultsBiotechnologyDownloadbiotechnology
06-23-2022Medexus Pharmaceuticals Inc. TSX-V:MDP4Q-2022 Results – Earnings Beat; Treosulfan Uncertainty RemainsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-22-2022Medicenna Therapeutics Corp. NASDAQ:MDNA; TSX:MDNAFY-2022 Results. ABILITY UpdateBiotechnologyDownloadbiotechnology
06-22-2022Xenon Pharmaceuticals Inc. NASDAQ:XENEEnd of Phase 2 Meeting with FDABiotechnologyDownloadbiotechnology
06-06-2022Microbix Biosystems Inc. TSX:MBXMicrobix Initiation: Steady Cash Flow and Significant Growth PotentialDiagnosticsDownloaddiagnostics
06-06-2022ESSA Pharma Inc. NASDAQ:EPIXEPI-7386 Phase 1a Results PreviewBiotechnologyDownloadbiotechnology
06-01-2022CloudMD Software & Services Inc. TSX-V:DOC1Q-2022 Results Beat Expectations but Macro Challenges WeighDigital HealthDownloaddigital-health
05-27-2022Zymeworks Inc. NYSE:ZYMEASCO 2022 Data Positive/MixedBiotechnologyDownloadbiotechnology
05-20-2022Chinook Therapeutics Inc. NASDAQ:KDNYERA Data: Best-in-Class Profile Emerging for AtrasentanBiotechnologyDownloadbiotechnology
05-20-2022BioSyent Inc. TSX-V:RX1Q-2022 Results – No SurprisesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-20-2022Hamilton Thorne Ltd. TSX-V:HTL1Q-2022 Impacted by Transient Issues. Still a Great Company – BUY the DipHealthcare ServicesDownloadhealthcare-services
05-19-2022Newtopia Inc. TSX-V:NEWU1Q-2022 Results in Line; Growth Challenges Continue, Downgrade to ACCUMULATEHealthcare ServicesDownloadhealthcare-services
05-19-2022Chinook Therapeutics Inc. NASDAQ:KDNYERA Data: BION-1301 Continues to ImpressBiotechnologyDownloadbiotechnology
05-17-2022Greenbrook TMS Inc. NASDAQ:GBNH, TSX:GTMS1Q-2021 Success…and Buying SuccessHealthcare ServicesDownloadhealthcare-services
05-17-2022Miravo Healthcare TSX:MRVMixed 1Q-2022 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-13-2022Miravo Healthcare TSX:MRVAnother Shoe Drops Unexpectedly – Reversal Possible, but More Likely NotSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-13-2022Knight Therapeutics Inc. TSX:GUDStrong 1Q-2022 – Raising Rating to BUYSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-11-2022Aurinia Pharmaceuticals Inc. NASDAQ:AUPHSolid 1Q-2022 Amidst OmicronBiotechnologyDownloadbiotechnology
05-11-2022AbCellera Biologics Inc. NASDAQ:ABCL1Q-2022 COVID Sales StrongBiotechnologyDownloadbiotechnology
05-10-2022Mimi’s Rock Corp. TSX-V:MIMIFiling Delay and Cease Trade OrderSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-09-2022AbCellera Biologics Inc. NASDAQ:ABCL1Q-2022 Financial Results PreviewBiotechnologyDownloadbiotechnology
05-05-2022Chinook Therapeutics Inc. NASDAQ:KDNYERA Abstracts: Gearing Up for Key Readouts for Atrasentan and BION-1301BiotechnologyDownloadbiotechnology
05-02-2022HLS Therapeutics Inc. TSX:HLSIn Support of C$250-$300M Peak Vascepa Sales (and near-term sales acceleration)Specialty PharmaceuticalDownloadspecialty-pharmaceutical
05-02-2022Zymeworks Inc. NYSE:ZYMENon-Binding Proposal to Acquire ZYME; ASCO PreviewBiotechnologyDownloadbiotechnology
04-26-2022HLS Therapeutics Inc. TSX:HLSTime for the Rubber to Hit the RoadSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-12-2022Repare Therapeutics Inc. NASDAQ:RPTXThe Rodney Dangerfield of Oncology DrugsBiotechnologyDownloadbiotechnology
04-08-2022Hamilton Thorne Ltd. TSX-V:HTL4Q-2021 Results BeatHealthcare ServicesDownloadhealthcare-services
04-07-2022Newtopia Inc. TSX-V:NEWU4Q-2021 Results – Weighed Down by Omicron; Upgrading to BUY on ValueHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
04-04-2022Greenbrook TMS Inc.NASDAQ:GBNH, TSX:GTMS4Q-2021 in Line. Focus Shifts to Increasing Utilization; Optimizing Costs; Strengthening Balance SheetHealthcare ServicesDownloadhealthcare-services
03-29-2022Miravo Healthcare TSX:MRV4Q-2021 Results MixedSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-25-2022Knight Therapeutics Inc. TSX:GUD4Q-2021 Results; 2022 Guidance Low due to Unanticipated LATAM RisksSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-18-2022HLS Therapeutics Inc. TSX:HLS4Q-2021 Missed Consensus; Vascepa On the CuspSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-10-2022BioSyent Inc. TSX-V:RX4Q-2021 Results – Chugging AlongSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-09-2022Viemed Healthcare Inc.NASDAQ:VMD, TSX:VMD4Q-2021 Results – Omicron BumpHealthcare ServicesDownloadhealthcare-services
03-08-2022Aurinia Pharmaceuticals Inc. NASDAQ:AUPHFlipping the IPR ProbabilitiesBiotechnologyDownloadbiotechnology
03-01-2022Aurinia Pharmaceuticals Inc.NASDAQ:AUPH4Q-2021 Results Inline; Guidance LowBiotechnologyDownloadbiotechnology
02-28-2022AbCellera Biologics Inc. NASDAQ:ABCLFY-2021 Results: Shifting Focus to Program Starts but Strategy UnchangedBiotechnologyDownloadbiotechnology
02-22-2022The Therapeutic WindowThe Therapeutic WindowSector ReportsDownloadsector-reports
02-17-2022Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.)NASDAQ:REUN; TSX:REUNFY-3Q Results – Clinic Buildout Distracting from FT-104BiotechnologyDownloadbiotechnology
02-11-2022Medexus Pharmaceuticals Inc.TSX-V:MDP3Q-2022 Results – Earnings Beat due to Order TimingSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-10-2022Aurinia Pharmaceuticals Inc.NASDAQ:AUPHPre-earnings COVID AdjustmentBiotechnologyDownloadbiotechnology
02-01-2022Zymeworks Inc.NYSE:ZYMEDilutive Financing a Risk Balancing ActBiotechnologyDownloadbiotechnology
01-25-2022Bellus Health Inc.NASDAQ:BLU; TSX: BLUOne Company’s Misfortune…BiotechnologyDownloadbiotechnology
01-14-2022MindBeacon Holdings Inc.TSX:MBCNDiscontinuing CoverageDigital HealthDownloaddigital-health
12-23-2021Medicenna Therapeutics Corp.NASDAQ:MDNA; TSX:MDNAABILITY Results Early, Limited but Encouraging vs Other IL-2 AgonistsBiotechnologyDownloadbiotechnology
12-22-2021CloudMD Software & ServicesTSX-V:DOCEvery Cloud Has a Silver LiningDigital HealthDownloaddigital-health
12-19-2021Abcellera BiologicsNASDAQ:ABCLAbCellera Initiation: Just Getting StartedBiotechnologyDownloadbiotechnology
12-17-2021Top Ideas2022 Top IdeasSector ReportsDownloadsector-reports
12-14-2021Zymeworks Inc.NYSE:ZYMEWe Think the Market is Wrong Thinking ZYME Doesn’t WorkBiotechnologyDownloadbiotechnology
12-13-2021Bellus Health Inc.NASDAQ:BLU; TSX: BLUQuick Reaction: SOOTHE-ing ResultsBiotechnologyDownloadbiotechnology
12-10-2021Aurinia Pharmaceuticals Inc.NASDAQ:AUPHAURORA 2 3-Year Safety Results – As Good as it Gets Without a BiopsyBiotechnologyDownloadbiotechnology
12-06-2021Xenon Pharmaceuticals Inc.NASDAQ:XENEAdditional XEN1101 Data Does Not Dampen Our EnthusiasmSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-01-2021Mimi’s Rock Corp.TSX-V:MIMI3Q-2021 Results: FX and Supply Chain Headwinds Result in Weaker QuarterSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-23-2021Hamilton Thorne Ltd.TSX-V:HTLMixed 3Q-2021 Results. Underlying Business Remains Strong – Pandemic Supply Chain Issues Impacted Revenues and MarginsHealthcare ServicesDownloadhealthcare-services
11-19-2021BioSyent Inc.TSX-V:RX3Q-2021 Results – Mixed QuarterSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-17-2021Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILDiscontinuing CoverageBiotechnologyDownloadbiotechnology
11-17-2021Miravo HealthcareTSX:MRV3Q-2021 Results Mixed. Remains UndervaluedSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-16-2021MindBeacon Holdings Inc.TSX:MBCN3Q-2021 Results; Moving Target to Acquisition Price, Rating to HOLDDigital HealthDownloaddigital-health
11-15-2021Titan Medical Inc.NASDAQ:TMDI; TSX:TMDLate in the Game DelayMedical TechnologyDownloadmedical-technology
11-12-2021Medexus Pharmaceuticals Inc.TSX-V:MDP2Q-2022 Results – No Major SurprisesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-12-2021Knight Therapeutics Inc.TSX:GUDStrong 3Q-2021 Financial Results Boosted by AntifungalsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-11-2021Newtopia Inc.TSX-V:NEWU3Q-2021 Results – Material COVID Impact ContinuesDigital HealthDownloaddigital-health
11-11-2021Greenbrook TMS Inc.NASDAQ:GBNH, TSX:GTMSSummer Fun Drives Lite 3Q-2021 – COVID Slump Should Turn to COVID BumpHealthcare ServicesDownloadhealthcare-services
11-10-2021Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.)NASDAQ:REUN; TSX:REUNCOMPASS Tracks South: COMP360 Phase 2b Results Generally Positive but Add Some UncertaintyBiotechnologyDownloadbiotechnology
11-05-2021HLS Therapeutics Inc.TSX:HLS3Q-2021 Results Mixed. PCPA Negotiations a Tough Slog – Blockbuster Tantalizingly CloseSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-05-2021Chinook Therapeutics Inc.NASDAQ:KDNYAdditional BION-1301 Data.BiotechnologyDownloadbiotechnology
11-04-2021Aurinia Pharmaceuticals Inc.NASDAQ:AUPH3Q-2021 Early Launch Tracking Well. Takeover Rumors Impacting SPBiotechnologyDownloadbiotechnology
11-03-2021Viemed Healthcare Inc.NASDAQ:VMD, TSX:VMD3Q-2021 Results Beat GuidanceHealthcare ServicesDownloadhealthcare-services
10-11-2021Repare Therapeutics Inc.NASDAQ:RPTXEarly RP-3500 Results Nuanced – Overall Supportive of Best-in-Class PotentialBiotechnologyDownloadbiotechnology
10-04-2021Xenon Pharmaceuticals Inc.NASDAQ:XENEXEN1101 Hits a HomerunBiotechnologyDownloadbiotechnology
10-01-2021Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILMoving Target to Acquisition Price (US$18.50); Rating to HOLDBiotechnologyDownloadbiotechnology
10-01-2021Aurinia Pharmaceuticals Inc.NASDAQ:AUPHHOLD on Stock AppreciationBiotechnologyDownloadbiotechnology
10-01-2021Greenbrook TMS Inc.NASDAQ:GBNH, TSX:GTMSAchieve TMS East/Central Acquisition Gets GBNH to Target, Supported by FinancingHealthcare ServicesDownloadhealthcare-services
09-30-2021Repare Therapeutics Inc.NASDAQ:RPTXInitial Phase 1/2 Results PreviewBiotechnologyDownloadbiotechnology
09-22-2021Medicenna Therapeutics Corp.NASDAQ:MDNA; TSX:MDNAABILITY PreviewBiotechnologyDownloadbiotechnology
09-16-2021Zymeworks Inc.NYSE:ZYMEMaturing NicelyBiotechnologyDownloadbiotechnology
09-14-2021Zymeworks Inc.NYSE:ZYMEEncouraging Initial Zanidatamab 1L GEA Phase 2 DataBiotechnologyDownloadbiotechnology
09-13-2021Bellus Health Inc.NASDAQ:BLU; TSX: BLUSOOTHE Administrative Interim Points to Positive Topline in 4QBiotechnologyDownloadbiotechnology
08-26-2021BioSyent Inc.TSX-V:RX2Q-2021 Results – Revenues BeatSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-18-2021Medexus Pharmaceuticals Inc.TSX-V:MDP1Q-2022 Results – U.S.Business Continues to DisappointSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-17-2021Chinook Therapeutics Inc.NASDAQ:KDNYTravere’s Sparsentan Validates ETA Inhibition in IgANBiotechnologyDownloadbiotechnology
08-17-2021HLS Therapeutics Inc.TSX:HLSWiser to Co-Promote with PfizerSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-16-2021Knight Therapeutics Inc.TSX:GUDStrong 2Q-2021 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-13-2021Bellus Health Inc.NASDAQ:BLU; TSX: BLU2Q-2021 Results. Upcoming Phase 2 (x2). Merck Gefapixant FDA Delay.BiotechnologyDownloadbiotechnology
08-10-2021Miravo HealthcareTSX:MRV2Q-2021 Results BeatSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-09-2021Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.)NASDAQ:REUN; TSX:REUNInitiation: The high Way to HappinessBiotechnologyDownloadbiotechnology
08-09-2021Greenbrook TMS Inc.NASDAQ:GBNH, TSX:GTMS2Q-2021 Financial Results in LineHealthcare ServicesDownloadhealthcare-services
08-06-2021Aurinia Pharmaceuticals Inc.NASDAQ:AUPH2Q-2021 Results – Lupkynis BeatsBiotechnologyDownloadbiotechnology
08-06-2021Mimi’s Rock Corp.TSX-V:MIMI2Q-2021 Results – Revenues Down, but Profitability UpSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-05-2021HLS Therapeutics Inc.TSX:HLS2Q-2021 Results. Vascepa Lite with COVID – Catalysts AheadSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-04-2021Medexus Pharmaceuticals Inc.TSX:MDPTreosulfan Delayed; Downgrading to HOLDSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-04-2021Viemed Healthcare Inc.NASDAQ:VMD, TSX:VMD2Q-2021 Financial ResultsHealthcare ServicesDownloadhealthcare-services
07-29-2021Greenbrook TMS Inc.NASDAQ:GBNH, TSX:GTMSUpdate and 2Q-2021 Results Preview. Adding (a bit of) Spravato to our ForecastsHealthcare ServicesDownloadhealthcare-services
07-29-2021MindBeacon Holdings Inc.TSX:MBCN2Q-2021 Financial Results Margin Pressures Likely TransientDigital HealthDownloaddigital-health
07-15-2021Hamilton Thorne Ltd.TSX-V:HTLIVFtech: A Bigger Accretive and Strategic AcquisitionHealthcare ServicesDownloadhealthcare-services
07-13-2021Xenon Pharmaceuticals Inc.NASDAQ:XENESetting the Stage for XEN1101BiotechnologyDownloadbiotechnology
06-18-2021Medexus Pharmaceuticals Inc.TSX:MDP4Q-2021 Financial Results Lite. No Alarms, Some SurprisesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-09-2021Chinook Therapeutics Inc.NASDAQ:KDNYBION-1301: Early POC Efficacy in IgANBiotechnologyDownloadbiotechnology
06-07-2021Liminial BioSciences IncNASDAQ:LMNLRyplazim Approved and Fezagepras Put on HoldBiotechnologyDownloadbiotechnology
05-28-2021BioSyent Inc.TSX-V:RXStrong 1Q-2021 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-28-2021Mimi’s Rock Corp.TSX-V:MIMI1Q-2021 Results: FX and Discounts Mask Volume GrowthSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-26-2021Chinook Therapeutics Inc.NASDAQ:KDNYCompetitor Stumbles, but Limited Readthrough to ChinookBiotechnologyDownloadbiotechnology
05-26-2021Hamilton Thorne Ltd.TSX-V:HTL1Q -2021 Results: Mixed Quarter but Overall Better Than ForecastHealthcare ServicesDownloadhealthcare-services
05-21-2021Newtopia Inc.TSX:NEWU1Q-2021 Results – Softer, but ExpectedDigital HealthDownloaddigital-health
05-21-2021Aurinia Pharmaceuticals Inc.NASDAQ:AUPHDouble Bonus – AURORA 2 Interim ResultsBiotechnologyDownloadbiotechnology
05-18-2021Liminal BioSciences Inc.NASDAQ:LMNLPlasma Business DivestmentBiotechnologyDownloadbiotechnology
05-18-2021Miravo HealthcareTSX:MRVMixed 1Q-2021 Results. EV/EBITDA remains low; D/E Remains HighSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-17-2021Knight Therapeutics Inc.TSX:GUD1Q-2021 Financial Results – Most Parts Moving in the Right DirectionSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-14-2021MindBeacon Holdings Inc.TSX:MBCN1Q-2021 Financial Results: Some Gives and TakesDigital HealthDownloaddigital-health
05-07-2021Aurinia Pharmaceuticals Inc.NASDAQ:AUPHFirst Quarter Lupkynis Sales Lite, but More Upside Than Downside at $12.34BiotechnologyDownloadbiotechnology
05-06-2021HLS Therapeutics Inc.TSX:HLS1Q-2021 Results In Line. Vascepa Momentum BuildingSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-05-2021Hamilton Thorne Ltd.TSX-V:HTLAnother Strategic Acquisition with Good Synergy PotentialHealthcare ServicesDownloadhealthcare-services
05-05-2021Viemed Healthcare Inc.NASDAQ:VMD, TSX:VMD1Q-2021 Financial Results In-Line 5Healthcare ServicesDownloadhealthcare-services
04-30-2021Mimi’s Rock Corp.TSX-V:MIMI4Q-2020 Financial Results: Amazon Prime Day Doesn’t DeliverSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-29-2021Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILR&D Day: More Monotx Responses- Wait Begins for Combo ResultsBiotechnologyDownloadbiotechnology
04-26-2021Knight Therapeutics Inc.TSX:GUDExelon Acquisition In Line With Our Valuation of GUD – Upside PossibleSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-23-2021CRH Medical Corp.NYSE MKT:CRHM, TSX:CRHDiscontinuing CoverageHealthcare ServicesDownloadhealthcare-services
04-19-2021Titan Medical Inc.NASDAQ:TMDI; TSX:TMDTMDI Initiation – Differentiated, Entering the Final StretchMedical TechnologyDownloadmedical-technology
04-15-2021Chinook Therapeutics Inc.NASDAQ:KDNYBION-1301 Coming Into FocusBiotechnologyDownloadbiotechnology
04-09-2021Repare Therapeutics Inc.NASDAQ:RPTXPromising 2nd Program UnveiledBiotechnologyDownloadbiotechnology
04-08-2021Hamilton Thorne Ltd.TSX-V:HTL4Q-2020 Financial ResultsHealthcare ServicesDownloadhealthcare-services
04-08-2021Newtopia Inc.TSX:NEWU4Q-2020 Financial ResultsDigital HealthDownloaddigital-health
04-01-2021Greenbrook TMS Inc.NASDAQ:GBNH, TSX:GTMS4Q-2020 Financial Results – Short term pain for long term gainHealthcare ServicesDownloadhealthcare-services
03-29-2021Medicenna Therapeutics Corp.NASDAQ:MDNA; TSX:MDNADon’t Look There…Look Here!BiotechnologyDownloadbiotechnology
03-26-2021Knight Therapeutics Inc.TSX:GUD4Q-2020 Financial Results – A Peek at Somewhat NormalSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-22-2021Chinook Therapeutics Inc.NASDAQ:KDNYChinook Initiation: Catch the WindBiotechnologyDownloadbiotechnology
03-10-2021Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ2 F2012 results in line with estimates. Price target to $2.25BiotechnologyDownloadbiotechnology
03-08-2021Novelion Therapeutics Inc.NASDAQ:NVLN1Q-2019 Financial ResultsBiotechnologyDownloadbiotechnology
03-08-2021HLS Therapeutics Inc.TSX:HLSVascepa Approved by Health Canada with Slightly Broader Label vs U.S.Specialty PharmaceuticalDownloadspecialty-pharmaceutical
03-05-2021Concordia International Corp.NASDAQ: CXRX, TSX: CXR3Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-23-2021Medexus Pharmaceuticals Inc.TSX-V:MDPTreosulfan Acquisition, FinancingSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-19-2021Hamilton Thorne Ltd.TSX-V:HTL4Q-2020 Preliminary ResultsHealthcare ServicesDownloadhealthcare-services
02-17-2021The Therapeutic WindowThe Therapeutic WindowSector ReportsDownloadsector-reports
02-12-2021ESSA Pharma Inc.NASDAQ:EPIXInitial EPI-7386 Phase 1 Results. Check. Check. BonusBiotechnologyDownloadbiotechnology
01-29-2021Liminal BioSciences Inc.NASDAQ:LMNLRyplazim ShelvedBiotechnologyDownloadbiotechnology
01-28-2021Zymeworks Inc.NYSE:ZYMESlow (but steady may win the race)BiotechnologyDownloadbiotechnology
01-25-2021Aurinia Pharmaceuticals Inc.NASDAQ:AUPHLUPKYNIS (voclosporin) ApprovedBiotechnologyDownloadbiotechnology
01-18-2021Zymeworks Inc.NYSE:ZYMEIncremental Zanidatamab Update. Key ZW49 Data Expected January 27BiotechnologyDownloadbiotechnology
12-23-2020CRH Medical Corp.NYSE MKT:CRHM, TSX:CRHDropped Ball or Hardball?Healthcare ServicesDownloadhealthcare-services
12-17-2020Fusion Pharmaceuticals Inc.NASDAQ: FUSNHammer TimeBiotechnologyDownloadbiotechnology
12-15-2020Top Ideas2021 Top IdeasSector ReportsDownloadsector-reports
12-13-2020HLS Therapeutics Inc.TSX:HLSEncouraging Early COVID-19 SignalSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-08-2020Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILSkinny ASH. But Tril (and CD47) Still Well PositionedBiotechnologyDownloadbiotechnology
12-06-2020Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILTT1-622:ASH Incremental/Mixed. Overall Profile Remains RobustBiotechnologyDownloadbiotechnology
11-27-2020BioSyent Inc.TSX-V:RX3Q-2020 Financial Results. Awaiting New Product Ramp UpsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-24-2020Mimi’s Rock Corp.TSX-V:MIMI3Q-2020 Financial Results. Not Prime Time but Recovery ContinuesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-20-2020Hamilton Thorne Ltd.TSX-V:HTL3Q-2020 Financial Results. Baby BounceHealthcare ServicesDownloadhealthcare-services
11-19-2020Liminal BioSciences Inc.NASDAQ:LMNLValuation Update Due to Recent Developments that Increase RiskBiotechnologyDownloadbiotechnology
11-18-2020Medexus Pharmaceuticals Inc.TSX-V:MDP2Q-2021 Financial Results. Uphill, but a Steady Climb NeverthelessSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-17-2020Nuvo Pharmaceuticals Inc.TSX:NRI3Q-2020 Financial Results. A Beat, With Some Help, During COVIDSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-17-2020HLS Therapeutics Inc.TSX:HLSPerseris PopSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-16-2020Knight Therapeutics Inc.TSX:GUD3Q-2020 Financial Results. Brisk COVID-19 Headwinds ContinueSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-16-2020CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH3Q-2020 Financial Results. Pushing Through the PandemicHealthcare ServicesDownloadhealthcare-services
11-16-2020Cipher Pharmaceuticals Inc.TSX:CPH3Q-2020 Financial Results. Lack of Near-Term DriversSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-13-2020Newtopia Inc.TSX:NEWU3Q-2020 Financial ResultsDigital HealthDownloaddigital-health
11-12-2020Greenbrook TMS Inc.TSX:GTMS3Q-2020 Financial ResultsHealthcare ServicesDownloadhealthcare-services
11-06-2020HLS Therapeutics Inc.TSX:HLS3Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-06-2020VieMed Healthcare Inc.NASDAQ:VMD, TSX:VMD3Q-2020 Financial ResultsHealthcare ServicesDownloadhealthcare-services
11-03-2020Aurinia Pharmaceuticals Inc.NASDAQ:AUPHVOS Comes up Dry (LN remains Attractive but AUPH less Diversified)BiotechnologyDownloadbiotechnology
10-19-2020VieMed Healthcare Inc.NASDAQ:VMD, TSX:VMDBreathing WellHealthcare ServicesDownloadhealthcare-services
10-16-2020Medicenna Therapeutics Corp.NASDAQ:MDNA; TSX:MDNAMdNA55 Phase 3 Shaping UpBiotechnologyDownloadbiotechnology
10-05-2020Liminal BioSciences Inc.NASDAQ:LMNLLiminal – Hold on Outlook and ValuationBiotechnologyDownloadbiotechnology
09-17-2020Repare Therapeutics Inc.NASDAQ:RPTXBig Lethal – Large-Scale Platform to Lead the Next Major Land Grab in OncologyBiotechnologyDownloadbiotechnology
09-17-2020HLS Therapeutics Inc.TSX:HLSDiversified High Margin Royalty Acquisition – Buffers Near-term COVID-19 Impact With Potential Long-term UpsideSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-09-2020Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILTrillium Therapeutics Inc. (NASDAQ:TRIL, US$9.46; TSX:TRIL, C$12.52)BiotechnologyDownloadbiotechnology
09-08-2020Bellus Health Inc.NASDAQ:BLU; TSX: BLUBack in the (Competitive) SaddleBiotechnologyDownloadbiotechnology
09-01-2020HLS Therapeutics Inc.TSX:HLSAdditional Support for Vascepa. Competitor Fails AgainSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-27-2020Mimi’s Rock Corp.TSX-V:MIMI2Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-27-2020BioSyent Inc.TSX-V:RX2Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-25-2020Greenbrook TMS Inc.NASDAQ:GBNH, TSX:GTMSTMS Device Vendors Doing Well. Who’s Next?Healthcare ServicesDownloadhealthcare-services
08-21-2020Hamilton Thorne Ltd.TSX-V:HTL2Q-2020 ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
08-14-2020Knight Therapeutics Inc.TSX:GUD2Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-14-2020Cipher Pharmaceuticals Inc.TSX:CPH2Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-13-2020Newtopia Inc.TSX-V:NEWU2Q-2020 Financial ResultsDigital HealthDownloaddigital-health
08-13-2020Medexus Pharmaceuticals Inc.TSX-V:MDP1Q-2021 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-13-2020Xenon Pharmaceuticals Inc.NASDAQ:XENEPipeline Update and Epilepsy Market OverviewBiotechnologyDownloadbiotechnology
08-12-2020CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH2Q-2020 Financial ResultsHealthcare ServicesDownloadhealthcare-services
08-11-2020Nuvo Pharmaceuticals Inc.TSX:NRI2Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-07-2020HLS Therapeutics Inc.TSX:HLS2Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-06-2020Newtopia Inc.TSX-V:NEWUTeladoc-Livongo Merger Brings Attractive NEWU Valuation into SpotlightDigital HealthDownloaddigital-health
08-06-2020Greenbrook TMS Inc.TSX:GTMS2Q-2020 ResultsHealthcare ServicesDownloadhealthcare-services
07-21-2020HLS Therapeutics Inc.TSX:HLSGood Pricing Outcome for VascepaSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-10-2020Zymeworks Inc.NYSE:ZYME1H-2020 Clinical and Corporate UpdateBiotechnologyDownloadbiotechnology
07-09-2020Newtopia Inc.TSX-V:NEWU1Q-2020 Financial ResultsDigital HealthDownloaddigital-health
07-09-2020HLS Therapeutics Inc.TSX:HLSDrug Pricing/Reimbursement Uncertainty in Canada – Bloom Burton’s Conservative Vascepa Pricing Assumptions Mitigate Valuation RiskSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-06-2020Bellus Health Inc.NASDAQ:BLU; TSX: BLUNo Relief from RELIEF – Primary Endpoint Missed. Still in the Race, But Substantially Higher RiskBiotechnologyDownloadbiotechnology
07-02-2020Mimi’s Rock Corp.TSX-V:MIMI1Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-29-2020Knight Therapeutics Inc.TSX:GUD1Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-24-2020Medexus Pharmaceuticals Inc.TSX-V:MDP4Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-17-2020Newtopia Inc.TSX-V:NEWU4Q-2019 Financial ResultsDigital HealthDownloaddigital-health
06-14-2020Zymeworks Inc.NYSE:ZYMEInitiation. No Better ZYME Than the PresentBiotechnologyDownloadbiotechnology
06-10-2020Aurinia Pharmaceuticals Inc.NASDAQ:AUPHAnother Brick in the Wall of Differentiation and Other NewsBiotechnologyDownloadbiotechnology
06-08-2020Mimi’s Rock Corp.TSX-V:MIMI4Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-02-2020HLS Therapeutics Inc.TSX:HLSSaladax MyCare Distribution AgreementSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-01-2020Hamilton Thorne Ltd.TSX-V:HTL1Q-2020 ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
05-29-2020Medicenna Therapeutics Corp.NASDAQ:MDNA; TSX:MDNAQuick ASCO Take – MDNA55BiotechnologyDownloadbiotechnology
05-29-2020Medicenna Therapeutics Corp.NASDAQ:MDNA; TSX:MDNAQuick ASCO Take –MDNA11 IL-2 SuperkineBiotechnologyDownloadbiotechnology
05-29-2020BioSyent Inc.TSX-V:RX1Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-29-2020Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILAdditional TTI-622 Monotherapy ActivityBiotechnologyDownloadbiotechnology
05-28-2020Bellus Health Inc.NASDAQ:BLU; TSX: BLUTakeaways from Virtual KOL MeetingBiotechnologyDownloadbiotechnology
05-27-2020Correvio Pharma Corp.NASDAQ:CRME, TSX:COMDiscontinuing CoverageSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-26-2020Liminal BioSciences Inc.TSX:LMNLCoverage TransitionBiotechnologyDownloadbiotechnology
05-26-2020Xenon Pharmaceuticals Inc.NASDAQ:XENECoverage TransitionBiotechnologyDownloadbiotechnology
05-24-2020Greenbrook TMS Inc.TSX:GTMSFinancing. 1Q-2020 Results. COVID OutlookHealthcare ServicesDownloadhealthcare-services
05-19-2020Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-19-2020ESSA Pharma Inc.NASDAQ:EPIXCompany Update – Value Inflection in SightBiotechnologyDownloadbiotechnology
05-14-2020CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH1Q-2020 Financial ResultsHealthcare ServicesDownloadhealthcare-services
05-12-2020Nuvo Pharmaceuticals Inc.TSX:NRI1Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-08-2020Cipher Pharmaceuticals Inc.TSX:CPH1Q-2020 Financial Results; Upgrading to ACCUMULATESpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-07-2020HLS Therapeutics Inc.TSX:HLS1Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-07-2020HLS Therapeutics Inc.TSX:HLS1Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-05-2020Newtopia Inc.TSX-V:NEWUResearch Initiation: Time for Something NewDigital HealthDownloaddigital-health
04-23-2020Hamilton Thorne Ltd.TSX-V:HTL4Q and FY-19 Results In Line; Near-term COVID Impact Uncertain, but HTL Remains a BUY for The Long TermHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
04-07-2020Bellus Health Inc.NASDAQ:BLU; TSX: BLUNot Ideal, But Outlook for P2 Trial Remains PositiveBiotechnologyDownloadbiotechnology
04-05-2020Xenon Pharmaceuticals Inc.NASDAQ:XENEProgress Despite COVID – Delays Priced InBiotechnologyDownloadbiotechnology
04-03-2020Bellus Health Inc.NASDAQ:BLU; TSX: BLUSpring Cleaning in Preparation for Summer.BiotechnologyDownloadbiotechnology
04-01-2020Knight Therapeutics Inc.TSX:GUD4Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-31-2020HLS Therapeutics Inc.TSX:HLSVascepa Patents Invalidated in the U.SSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-26-2020Cipher Pharmaceuticals Inc.TSX:CPH4Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-25-2020Advanz Pharma Corp.TSX:ADVZ4Q-2019 Results – Going out on a Strong Note. Discontinuing CoverageSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-20-2020HLS Therapeutics Inc.TSX:HLS4Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-19-2020Aurinia Pharmaceuticals Inc.NASDAQ:AUPHCOVID Correction: Phase 3 Completed SuccessfullyBiotechnologyDownloadbiotechnology
03-19-2020Aurinia Pharmaceuticals Inc.NASDAQ:AUPHCOVID Correction: Phase 3 Completed SuccessfullyBiotechnologyDownloadbiotechnology
03-19-2020Aurinia Pharmaceuticals Inc.NASDAQ:AUPHCOVID Correction: Phase 3 Completed SuccessfullyBiotechnologyDownloadbiotechnology
03-19-2020BioSyent Inc.TSX-V:RX4Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-19-2020Xenon Pharmaceuticals Inc.NASDAQ:XENECOVID Correction: 6 CNS Programs; 3 Good Partners; $225 MM Cash; $65 MM EV; Key Data this Year (Maybe)BiotechnologyDownloadbiotechnology
03-13-2020CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH4Q-2019 Financial ResultsHealthcare ServicesDownloadhealthcare-services
03-09-2020Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-02-2020Medexus Pharmaceuticals Inc.TSX-V:MDPFIX and BuildSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-26-2020Nuvo Pharmaceuticals Inc.TSX:NRI4Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-20-2020Medexus Pharmaceuticals Inc.TSX-V:MDP3Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-20-2020Hamilton Thorne Ltd.TSX-V:HTLNot Crowning, but Contractions 2 Minutes ApartHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
02-10-2020Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-06-2020The Therapeutic WindowThe Therapeutic WindowSector ReportsDownloadsector-reports
01-30-2020Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILClosing of US$117 MM Public OfferingBiotechnologyDownloadbiotechnology
01-29-2020Xenon Pharmaceuticals Inc.NASDAQ:XENEClosing of $60 MM Public OfferingBiotechnologyDownloadbiotechnology
01-29-2020HLS Therapeutics Inc.TSX:HLSVascepa Launch and Pricing UpdateSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
01-25-2020MindBeacon Holdings Inc.TSX:MBCNShining the Light on Digital Mental HealthDigital HealthDownloaddigital-health
01-19-2020Cipher Pharmaceuticals Inc.TSX:CPHDiscontinuing CoverageSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
01-14-2020HLS Therapeutics Inc.TSX:HLSVascepa Competitors Fail in Clinical TrialsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
01-08-2020Nuvo Pharmaceuticals Inc.TSX:NRINot Reddy for Generic Vimovo Just Yet (V2)Specialty PharmaceuticalDownloadspecialty-pharmaceutical
01-08-2020Transition Therapeutics Inc.NASDAQ:TRIL, TSX:TRILHigher Doses Add New Responses Without Increasing Safety RiskBiotechnologyDownloadbiotechnology
01-06-2020HLS Therapeutics Inc.TSX:HLSPotential Extra Layers of IP Protection – Score 1 TodaySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
01-06-2020HLS Therapeutics Inc.TSX:HLSPotential Extra Layers of IP ProtectionSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-16-2019HLS Therapeutics Inc.TSX:HLSNew U.S. Vascepa Label Extends to Large Patient PopulationSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-13-2019Aurinia Pharmaceuticals Inc.NASDAQ:AUPHUS$192 MM Financing ClosedBiotechnologyDownloadbiotechnology
12-13-2019Correvio Pharma Corp.NASDAQ:CRME, TSX:COMRisky, but We Think OversoldSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-10-2019Correvio Pharma Corp.NASDAQ:CRME, TSX:COMNegative AdComSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-09-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-09-2019HLS Therapeutics Inc.TSX:HLSScenariopaloozaSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-06-2019Correvio Pharma Corp.NASDAQ:CRME, TSX:COMNegative Briefing DocumentsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-05-2019Aurinia Pharmaceuticals Inc.NASDAQ:AUPHAURORA Borealis!BiotechnologyDownloadbiotechnology
12-03-2019Medexus Pharmaceuticals Inc.TSX-V:MDP2Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-03-2019Xenon Pharmaceuticals Inc.NASDAQ:XENEXEN901 License Agreement with NeurocrineBiotechnologyDownloadbiotechnology
12-02-2019Mimi’s Rock Corp.TSX-V:MIMI3Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-22-2019Hamilton Thorne Ltd.TSX-V:HTL3Q-2019 Financial ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
11-21-2019BioSyent Inc.TSX-V:RX3Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-19-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-15-2019HLS Therapeutics Inc.TSX:HLSAdCom Votes Unanimously in Favor of sNDA ApprovalSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-15-2019Correvio Pharma Corp.NASDAQ:CRME, TSX:COM3Q-2019 Financial Results. Prepping for AdComSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-15-2019Correvio Pharma Corp.NASDAQ:CRME, TSX:COM3Q-2019 Financial Results. Prepping for AdComSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-14-2019Knight Therapeutics Inc.TSX:GUD3Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-13-2019Aurinia Pharmaceuticals Inc.NASDAQ:AUPHGazyva Results Improved at 76 Weeks, But Voclosporin Opportunity Remains HighBiotechnologyDownloadbiotechnology
11-13-2019HLS Therapeutics Inc.TSX:HLSVascepa AdCom Briefing DocumentsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-12-2019Nuvo Pharmaceuticals Inc.TSX:NRINot Reddy for Generic Vimovo Just YetSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-11-2019CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH3Q-2019 Financial ResultsHealthcare ServicesDownloadhealthcare-services
11-08-2019HLS Therapeutics Inc.TSX:HLS3Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-08-2019Advanz Pharma Corp.TSX:ADVZ3Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-08-2019Cipher Pharmaceuticals Inc.TSX:CPH3Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-06-2019Greenbrook TMS NeuroHealth Inc.TSX:GTMS3Q-2019 Financial ResultsHealthcare ServicesDownloadhealthcare-services
11-01-2019Nuvo Pharmaceuticals Inc.TSX:NRI3Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-22-2019Knight Therapeutics Inc.TSX:GUDGUD Salsa – Back to the Business of Selling DrugsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-21-2019Nuvo Pharmaceuticals Inc.TSX:NRIPotentially Good News for U.S. VIMOVO. Hurdles Remain but Currently not in Mid/Long-term Forecasts – Upside PossibleSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-18-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-04-2019HLS Therapeutics Inc.TSX:HLSKOLing HLS a Speculative BUYSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-01-2019Bellus Health Inc.NASDAQ:BLU; TSX: BLUArigato ShionogiBiotechnologyDownloadbiotechnology
09-12-2019Greenbrook TMS NeuroHealth Inc.TSX:GTMSAcquisition Achieves Strategic Benefits – Financial Details ForthcomingHealthcare ServicesDownloadhealthcare-services
09-10-2019Hamilton Thorne Ltd.TSX-V:HTLFDA Clearance of First Media Product (+ some new CE Marks)Healthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
09-09-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-09-2019CannTrust Holdings Inc.CSE:TRSTDiscontinuing Coverage: TRSTMedical MarijuanaDownloadmedical-marijuana
09-06-2019Bellus Health Inc.NASDAQ:BLU; TSX: BLUShare Consolidation and NASDAQ IPOBiotechnologyDownloadbiotechnology
09-06-2019Mimi’s Rock Corp.TSX-V:MIMIStrategic Acquisition Immediately Adds to EBITDA with Potential Cross-Selling OpportunitiesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-30-2019Mimi’s Rock Corp.TSX-V:MIMI2Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-28-2019ESSA Pharma Inc.NASDAQ:EPIXBalance Sheet Strengthened – Path to Potential Monetization ClearBiotechnologyDownloadbiotechnology
08-28-2019Hamilton Thorne Ltd.TSX-V:HTL2Q-2019 Financial ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
08-23-2019Medexus Pharmaceuticals Inc.TSX-V:MDP1Q-2020 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-15-2019Nuvo Pharmaceuticals Inc.TSX:NRI2Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-14-2019Hamilton Thorne Ltd.TSX-V:HTLPlane to See Immediate EBITDA Uptick and Future Potential SynergyHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
08-12-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-12-2019Cipher Pharmaceuticals Inc.TSX:CPH2Q-2019 Results and Strategic UpdateSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-09-2019HLS Therapeutics Inc.TSX:HLS2Q-2019 Financial Results and AdCom for VascepaSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-09-2019Knight Therapeutics Inc.TSX:GUD2Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-08-2019Greenbrook TMS NeuroHealth Inc.TSX:GTMS2Q-2019 Financial ResultsHealthcare ServicesDownloadhealthcare-services
08-08-2019Advanz Pharma Corp.TSX:ADVZ2Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-01-2019Bellus Health Inc.NASDAQ:BLU; TSX: BLUMarket Visibility Increasing. Ying/Yang of Competitors’ ResultsBiotechnologyDownloadbiotechnology
08-01-2019CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH2Q-2019 Financial Results; 2020 Proposed Fee ScheduleHealthcare ServicesDownloadhealthcare-services
07-30-2019Cipher Pharmaceuticals Inc.TSX:CPH2Q-2019 Preliminary Results, Management Change. Rating Under ReviewSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-25-2019Correvio Pharma Corp.NASDAQ:CRME, TSX:COMMark Late November and Christmas Eve on Your CalendarsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-24-2019CannTrust Holdings Inc.CSE:TRSTRating to Under ReviewMedical MarijuanaDownloadmedical-marijuana
07-22-2019Mimi’s Rock Corp.TSX-V:MIMIResearch Initiation: Online Brand Leader Expanding ChannelsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-12-2019Xenon Pharmaceuticals Inc.NASDAQ:XENEValuation UpdateBiotechnologyDownloadbiotechnology
07-10-2019CannTrust Holdings Inc.CSE:TRSTWhat were they thinking?Medical MarijuanaDownloadmedical-marijuana
07-09-2019Medexus Pharmaceuticals Inc.TSX-V:MDP4Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-08-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-03-2019Medexus Pharmaceuticals Inc.TSX-V:MDPResearch Initiation: Bigger and More DiverseSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-27-2019HLS Therapeutics Inc.TSX:HLSUpdate – Financing, Vascepa, PerserisSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-18-2019Nuvo Pharmaceuticals Inc.TSX:NRICorporate UpdateSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-18-2019Nuvo Pharmaceuticals Inc.TSX:NRICorporate UpdateSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-13-2019Aurinia Pharmaceuticals Inc.NASDAQ:AUPHFiltering the Noise. Nearing a High Probability Phase 3 ReadoutBiotechnologyDownloadbiotechnology
06-10-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-06-2019Xenon Pharmaceuticals Inc.NASDAQ:XENEXEN901 Clinical UpdateBiotechnologyDownloadbiotechnology
05-24-2019Hamilton Thorne Ltd.TSX-V:HTL1Q-2019 Financial ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
05-22-2019Greenbrook TMS NeuroHealth Inc.TSX:GTMS1Q-2019 Results and FinancingHealthcare ServicesDownloadhealthcare-services
05-22-2019Novelion Therapeutics Inc.NASDAQ:NVLN, NASDAQ: CMTA, OTC:ARLZQDiscontinuing Coverage: NVLN; CMTA; ARLZQBiotechnologyDownloadbiotechnology
05-16-2019Nuvo Pharmaceuticals Inc.TSX:NRIAppeals Court Ruling Opens Door to Potential U.S. Vimovo GenericsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-15-2019Nuvo Pharmaceuticals Inc.TSX:NRI1Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-15-2019CannTrust Holdings Inc.CSE:TRST1Q-2019 Financial ResultsMedical MarijuanaDownloadmedical-marijuana
05-13-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-13-2019Advanz Pharma Corp.TSX:ADVZ1Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-13-2019Cipher Pharmaceuticals Inc.TSX:CPH1Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-10-2019HLS Therapeutics Inc.TSX:HLS1Q-2019 Financial Results and New Product LicenseSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-10-2019Knight Therapeutics Inc.TSX:GUD1Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-09-2019Correvio Pharma Corp.NASDAQ:CRME, TSX:COM1Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-03-2019CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH1Q-2019 Financial ResultsHealthcare ServicesDownloadhealthcare-services
04-30-2019Hamilton Thorne Ltd.TSX-V:HTL4Q-2018 Full Financial ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
04-24-2019Knight Therapeutics Inc.TSX:GUDCurrent Management, Board, Strategy the Better Choice for GUD Investors in our Opinion (With One Borrowed Idea)Specialty PharmaceuticalDownloadspecialty-pharmaceutical
04-10-2019Greenbrook TMS NeuroHealth Inc.TSX:GTMSGreenbrook Selected by Kaiser PermanenteHealthcare ServicesDownloadhealthcare-services
04-08-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-03-2019Prometic Life Sciences Inc.TSX:PLIRemoving Target and Forecasts Pending RecapitalizationBiotechnologyDownloadbiotechnology
04-01-2019Nuvo Pharmaceuticals Inc.TSX:NRI4Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-01-2019HLS Therapeutics Inc.TSX:HLSPriority Review for VascepaSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-29-2019Greenbrook TMS NeuroHealth Inc.TSX:GTMS4Q-2018 Financial ResultsHealthcare ServicesDownloadhealthcare-services
03-22-2019HLS Therapeutics Inc.TSX:HLS4Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-20-2019Cipher Pharmaceuticals Inc.TSX:CPH4Q-2018 Financial Results. Attractive Valuation; Upgrading to BUY.Specialty PharmaceuticalDownloadspecialty-pharmaceutical
03-19-2019Bellus Health Inc.NASDAQ:BLU; TSX: BLUCOVID Correction; Almost Finished Transformational Phase 2 TrialBiotechnologyDownloadbiotechnology
03-18-2019Novelion Therapeutics Inc.NASDAQ:NVLN4Q-2018 Financial ResultsBiotechnologyDownloadbiotechnology
03-15-2019Knight Therapeutics Inc.TSX:GUD4Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-15-2019Advanz Pharma Corp.TSX:ADVZ4Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-14-2019CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH4Q-2018 Financial ResultsHealthcare ServicesDownloadhealthcare-services
03-14-2019Correvio Pharma Corp.NASDAQ:CRME, TSX:COM4Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-12-2019Greenbrook TMS Inc.TSX:GTMS4Q-2019 Financial ResultsHealthcare ServicesDownloadhealthcare-services
03-11-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-26-2019Clementia Pharmaceuticals Inc.NASDAQ:CMTA$1 + $0.3 B Acquisition Agreement AnnounceBiotechnologyDownloadbiotechnology
02-25-2019Aurinia Pharmaceuticals Inc.NASDAQ:AUPHAnother Brick in Aurinia’s IP Wall May Add 10 Years of Additional Protection Vs Generics. Other Possible Value Lifts This YearBiotechnologyDownloadbiotechnology
02-25-2019Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRFinancing Blows-up Share Count; Resets Near-Term Expectations; Highlights Missed Opportunities. But, We Don’t Think Investors Should Throw in the TowelBiotechnologyDownloadbiotechnology
02-19-2019Hamilton Thorne Ltd.TSX-V:HTL4Q-2018 Preliminary Results – Attractive Industry and Business Strategy Beginning to CoalesceHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
02-19-2019Hamilton Thorne Ltd.TSX-V:HTL4Q-2018 Preliminary Results – Attractive Industry and Business Strategy Beginning to CoalesceHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
02-15-2019ESSA Pharma Inc.NASDAQ:EPIXSearch for Ideal Lead Nearing Completion – Long Methodical Process Should Pay-off Long Term, but Likely Necessitates Additional Cash InfusionBiotechnologyDownloadbiotechnology
02-07-2019Medicenna Therapeutics Corp.NASDAQ:MDNA; TSX:MDNAResearch Initiation: Superkine’dBiotechnologyDownloadbiotechnology
01-24-2019The Therapeutic WindowThe Therapeutic WindowSector ReportsDownloadsector-reports
01-23-2019Aurinia Pharmaceuticals Inc.NASDAQ:AUPHBuy the EyeBiotechnologyDownloadbiotechnology
01-14-2019Knight Therapeutics Inc.TSX:GUDGUD Early Move into Oncology – NERLYNX LicenseSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
01-14-2019Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-31-2018Nuvo Pharmaceuticals Inc.TSX:NRINEWVO – Aralez Asset Acquisition ClosedSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-17-2018Clementia Pharmaceuticals Inc.NASDAQ:CMTAHigh Value, High Probability Orphan CandidateBiotechnologyDownloadbiotechnology
12-10-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-04-2018Xenon Pharmaceuticals Inc.NASDAQ:XENEXEN1101 and XEN901 Clinical UpdatesBiotechnologyDownloadbiotechnology
11-22-2018BioSyent Inc.TSX-V:RX3Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-21-2018Hamilton Thorne Ltd.TSX-V:HTL3Q-2018 Financial ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
11-20-2018Bellus Health Inc.NASDAQ:BLU; TSX: BLUBLU-5937 Phase 1 – Solid Step Toward Potential Best-in-ClassBiotechnologyDownloadbiotechnology
11-16-2018HLS Therapeutics Inc.TSX-V:HLS3Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-16-2018CannTrust Holdings Inc.CSE:TRST3Q-2018 Financial ResultsMedical MarijuanaDownloadmedical-marijuana
11-14-2018Greenbrook TMS NeuroHealth Inc.TSX:GTMS3Q-2018 Financial ResultsHealthcare ServicesDownloadhealthcare-services
11-13-2018Novelion Therapeutics Inc.NASDAQ:NVLN3Q-2018 Financial Results; Short Fuse Bridge FinancingBiotechnologyDownloadbiotechnology
11-12-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-11-2018HLS Therapeutics Inc.TSX-V:HLSREDUCE-IT Increases ItSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-09-2018Nuvo Pharmaceuticals Inc.TSX:NRI3Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-09-2018Knight Therapeutics Inc.TSX:GUD3Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-08-2018Cipher Pharmaceuticals Inc.TSX:CPH3Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-08-2018Correvio Pharma Corp.NASDAQ:CRME, TSX:COM3Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-02-2018CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH3Q-2018 Financial ResultsHealthcare ServicesDownloadhealthcare-services
10-25-2018HLS Therapeutics Inc.TSX-V:HLSPotential Clozaril Competitor FailsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-17-2018Xenon Pharmaceuticals Inc.NASDAQ:XENEGDC-0310 Terminated by Genentech/RocheBiotechnologyDownloadbiotechnology
10-17-2018Arbutus Biopharma CorporationNASDAQ: ABUSDiscontinuing CoverageBiotechnologyDownloadbiotechnology
10-15-2018HLS Therapeutics Inc.TSX-V:HLSKOL Call Highlights – The Good, The Uncertain, and What to Look For at AHASpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-10-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-09-2018HLS Therapeutics Inc.TSX-V:HLSInvestor Invitation: Bloom Burton Vascepa Call With a Dyslipidemia KOLSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-03-2018Greenbrook TMS NeuroHealth Inc.TSX:GTMSResearch Initiation: Flowing into a Greenfield OpportunityHealthcare ServicesDownloadhealthcare-services
10-03-2018Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRTTI-621-01 and -02 Trial UpdatesBiotechnologyDownloadbiotechnology
09-27-2018Aurinia Pharmaceuticals Inc.NASDAQ:AUPHAURORA Enrollment CompletedBiotechnologyDownloadbiotechnology
09-25-2018HLS Therapeutics Inc.TSX-V:HLSBetter Bigger VascepaSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-24-2018Nuvo Pharmaceuticals Inc.TSX:NRIDefinitive Agreement Signed for Acquisition of Aralez AssetsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-19-2018Cipher Pharmaceuticals Inc.TSX:CPHDerm Pipeline Build Continues with MOB-015. Model UpdateSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-11-2018Concordia International Corp.NASDAQ: CXRX, TSX: CXRRestructuring and Share Consolidation CompleteSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-10-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-07-2018Xenon Pharmaceuticals Inc.NASDAQ:XENEInnovative Pipeline Build Continues with XEN496BiotechnologyDownloadbiotechnology
09-06-2018Correvio Pharma Corp.NASDAQ:CRME, TSX:COMSPECTRUM Increases Odds of Brinavess Approval in U.SSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-30-2018Xenon Pharmaceuticals Inc.NASDAQ:XENEAdditional XEN1101 TMS DataBiotechnologyDownloadbiotechnology
08-26-2018BioSyent Inc.TSX-V:RX2Q-2019 Results. Upgrading to BUY on ValuationSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-23-2018BioSyent Inc.TSX-V:RX2Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-23-2018Hamilton Thorne Ltd.TSX-V:HTL2Q-2018 Financial ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
08-16-2018HLS Therapeutics Inc.TSX-V:HLS2Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-15-2018CannTrust Holdings Inc.CSE:TRST2Q-2018 Financial ResultsMedical MarijuanaDownloadmedical-marijuana
08-15-2018Correvio Pharma Corp.NASDAQ:CRME, TSX:COM2Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-13-2018Nuvo Pharmaceuticals Inc.TSX:NRILOI Signed for Potentially Transformative Deal. Positive 2Q2018 ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-13-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-13-2018Cipher Pharmaceuticals Inc.TSX:CPH2Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-10-2018Knight Therapeutics Inc.TSX:GUD2Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-10-2018Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZEnd of the Line. Likely No (or Nominal) Value for EquitySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-08-2018Novelion Therapeutics Inc.NASDAQ:NVLN2Q-2018 Financial ResultsBiotechnologyDownloadbiotechnology
07-31-2018Cipher Pharmaceuticals Inc.TSX:CPHAmended Absorica Distribution AgreementSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-20-2018Hamilton Thorne Ltd.TSX-V:HTLZANDAIR AcquisitionHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
07-17-2018Xenon Pharmaceuticals Inc.NASDAQ:XENEATM Share Sales Strengthen Balance Sheet; Reduce RiskBiotechnologyDownloadbiotechnology
07-09-2018Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRTRIL Update, Forty Seven ASCO Results and IPOBiotechnologyDownloadbiotechnology
07-06-2018Bellus Health Inc.NASDAQ:BLU; TSX: BLUSexy P2X-i (Update) – Clinical Milestones Coming into FocusBiotechnologyDownloadbiotechnology
06-29-2018CannTrust Holdings Inc.CSE:TRSTPost-financing Update. Days Ahead Will Separate Boys from MenMedical MarijuanaDownloadmedical-marijuana
06-21-2018Knight Therapeutics Inc.TSX:GUDUpdating Sum-of-Parts Valuation; Pondering StrategySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-12-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-12-2018Correvio Pharma Corp.NASDAQ:CRME, TSX:COMU.S. Regulatory Update for BRINAVESS (IV vernakalant)Specialty PharmaceuticalDownloadspecialty-pharmaceutical
06-04-2018Novelion Therapeutics Inc.NASDAQ:NVLNPositive CHMP Opinion for MYALEPTA – Two IndicationsBiotechnologyDownloadbiotechnology
05-31-2018BioSyent Inc.TSX-V:RX1Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-30-2018BioSyent Inc.TSX-V:RX1Q-2019 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-25-2018Hamilton Thorne Ltd.TSX-V:HTL1Q-2018 Financial ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
05-17-2018HLS Therapeutics Inc.TSX-V:HLS1Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-17-2018Correvio Pharma Corp.NASDAQ:CRME, TSX:COM1Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-15-2018Xenon Pharmaceuticals Inc.NASDAQ:XENEPositive Safety and PD – XEN1101, XEN901 Interim Phase 1 DataBiotechnologyDownloadbiotechnology
05-11-2018Novelion Therapeutics Inc.NASDAQ:NVLN1Q-2018 Financial ResultsBiotechnologyDownloadbiotechnology
05-11-2018Nuvo Pharmaceuticals Inc.TSX:NRI1Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-11-2018Knight Therapeutics Inc.TSX:GUD1Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-11-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-11-2018Cipher Pharmaceuticals Inc.TSX:CPH1Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-09-2018Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZ1Q-2018 Results: Improving Performance not Enough to Support Ongoing Zontivity Sales and Marketing; Prompts Major RestructureSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-08-2018Novelion Therapeutics Inc.NASDAQ:NVLN1Q-2018 Financial Results PreviewBiotechnologyDownloadbiotechnology
04-30-2018Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMUnited Therapeutics to Acquire SteadyMedSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-30-2018Prometic Life Sciences Inc.TSX:PLIPositive Interim IVIG DataBiotechnologyDownloadbiotechnology
04-26-2018Hamilton Thorne Ltd.TSX-V:HTL4Q-2017 Financial ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
04-24-2018HLS Therapeutics Inc.TSX-V:HLSAbsorica updateSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-24-2018Cipher Pharmaceuticals Inc.TSX:CPHPreliminary 1Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-23-2018Concordia International Corp.NASDAQ: CXRX, TSX: CXREstimates RevisionSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-09-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-06-2018Hamilton Thorne Ltd.TSX-V:HTLHooking-up to Make BabiesHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
04-05-2018CannTrust Holdings Inc.CSE:TRST4Q-2017 ResultsMedical MarijuanaDownloadmedical-marijuana
04-02-2018HLS Therapeutics Inc.TSX-V:HLS4Q-2017 ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-29-2018Prometic Life Sciences Inc.TSX:PLI4Q-2017 Financial ResultsBiotechnologyDownloadbiotechnology
03-29-2018CannTrust Holdings Inc.CSE:TRST4Q-2018 Financial ResultsMedical MarijuanaDownloadmedical-marijuana
03-26-2018Nuvo Pharmaceuticals Inc.TSX:NRI4Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-22-2018BioSyent Inc.TSX-V:RX4Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-21-2018Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMWINSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-21-2018BioSyent Inc.TSX-V:RX4Q-2018 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-21-2018Cipher Pharmaceuticals Inc.TSX:CPHWinSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-19-2018Novelion Therapeutics Inc.NASDAQ:NVLN4Q-2017 Financial ResultsBiotechnologyDownloadbiotechnology
03-16-2018Knight Therapeutics Inc.TSX:GUD4Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-15-2018Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM4Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-14-2018Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZ4Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-12-2018HLS Therapeutics Inc.TSX-V:HLSResearch Initiation – HLS’ BellesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-12-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-09-2018Xenon Pharmaceuticals Inc.NASDAQ:XENE4Q-2017 Financial Results and New Migraine ProgramBiotechnologyDownloadbiotechnology
03-01-2018Cipher Pharmaceuticals Inc.TSX:CPH4Q-2017 Financial Results. Trulance AcquisitionSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-16-2018CannTrust Holdings Inc.CSE:TRSTThriving in the Depths of Winter – Well-Positioned for Rec and InternationalMedical MarijuanaDownloadmedical-marijuana
02-14-2018Hamilton Thorne Ltd.TSX-V:HTL4Q-2017 Preliminary Revenues and Adjusted EBITDAHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
02-12-2018Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-01-2018Novelion Therapeutics Inc.NASDAQ:NVLNOne Major Overhang Resolved Favorably: Judge’s SentencingBiotechnologyDownloadbiotechnology
01-27-2018The Therapeutic WindowThe Therapeutic WindowSector ReportsDownloadsector-reports
01-18-2018ESSA Pharma Inc.NASDAQ:EPIXCashed-up + Great Target + Lessons Learned = Ideal Reset SPEC BUYBiotechnologyDownloadbiotechnology
01-16-2018Nuvo Pharmaceuticals Inc.TSX:NRIU.S. Licensing Agreement Extends Rights to Resultz GloballySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
01-03-2018Nuvo Pharmaceuticals Inc.TSX:NRIResultz – Small But Strategic (and Impactful on 11.6 MM Share Base)Specialty PharmaceuticalDownloadspecialty-pharmaceutical
01-01-2018Top Ideas2018 Top Ideas; Healthcare Sector Review/PreviewSector ReportsDownloadsector-reports
12-12-2017Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRASH 2017 Mixed for TRIL, But a Potential Path EmergingBiotechnologyDownloadbiotechnology
12-11-2017Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-24-2017CannTrust Holdings Inc.CSE:TRST3Q-2017 Financial ResultsMedical MarijuanaDownloadmedical-marijuana
11-23-2017Hamilton Thorne Ltd.TSX-V:HTL3Q-2017 Financial ResultsHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
11-23-2017Prometic Life Sciences Inc.TSX:PLIIVIG Interim 6-Month UpdateBiotechnologyDownloadbiotechnology
11-16-2017BioSyent Inc.TSX-V:RX3Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-15-2017Concordia International Corp.NASDAQ: CXRX, TSX: CXRSpecialty PharmaceuticalSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-15-2017Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM3Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-13-2017Novelion Therapeutics Inc.NASDAQ:NVLNUpdate on the DOJ SettlementBiotechnologyDownloadbiotechnology
11-13-2017Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-13-2017Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILSITC Posters: Incremental Efficacy/PD Color; No New Safety Red Flags – More Details Expected at ASHBiotechnologyDownloadbiotechnology
11-10-2017Novelion Therapeutics Inc.NASDAQ:NVLNWeak 3Q-2017 Results; Leadership ChangeBiotechnologyDownloadbiotechnology
11-10-2017Knight Therapeutics Inc.TSX:GUD3Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-10-2017Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZ3Q-2017 Financial Results. The Ship is TurningSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-08-2017Xenon Pharmaceuticals Inc.NASDAQ:XENEGDC-0310 Shoe Drops (almost completely)BiotechnologyDownloadbiotechnology
11-08-2017Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRILSITC AbstractsBiotechnologyDownloadbiotechnology
11-06-2017Cipher Pharmaceuticals Inc.TSX:CPH3Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-03-2017Nuvo Pharmaceuticals Inc.TSX:NRI3Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-02-2017Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRTRIL Rebounding from Last Year’s ASH KickingBiotechnologyDownloadbiotechnology
10-27-2017Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZCOMPASS Likely to Impact Zontivity Path to SuccessSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-25-2017Aurinia Pharmaceuticals Inc.NASDAQ:AUPHPotential New Indications for VoclosporinBiotechnologyDownloadbiotechnology
10-24-2017Hamilton Thorne Ltd.TSX-V:HTLResearch Initiation: Be My BabyHealthcare Equipment and SuppliesDownloadhealthcare-equipment-supplies
10-18-2017Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRA Small Positive Step on the Path to ASH 2017BiotechnologyDownloadbiotechnology
10-16-2017Prometic Life Sciences Inc.TSX:PLIBetter Late than NeverBiotechnologyDownloadbiotechnology
10-13-2017CannTrust Holdings Inc.CSE:TRSTCannTrust Update – Metrics and MilestonesMedical MarijuanaDownloadmedical-marijuana
10-12-2017Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-29-2017Bellus Health Inc.NASDAQ:BLU; TSX: BLUSexy P2X-iBiotechnologyDownloadbiotechnology
09-26-2017Arbutus Biopharma CorporationNASDAQ: ABUSCohort 4 (Bi-Weekly) Data from the ARB-1467 Phase 2 TrialBiotechnologyDownloadbiotechnology
09-26-2017Prometic Life Sciences Inc.TSX:PLIProbability of a PRVBiotechnologyDownloadbiotechnology
09-20-2017Arbutus Biopharma CorporationNASDAQ: ABUSPositive Phase 3 Results for Patisiran – Gas for the BUS!BiotechnologyDownloadbiotechnology
09-20-2017Prometic Life Sciences Inc.TSX:PLIAnother Alström Syndrome InterimBiotechnologyDownloadbiotechnology
09-18-2017Bellus Health Inc.NASDAQ:BLU; TSX: BLUBLU-5937 Preclinical Head-to-Head Results vs Merck Comp Leave a Good Taste in Our MouthBiotechnologyDownloadbiotechnology
09-13-2017Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMZevtera License DealSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-12-2017ESSA Pharma Inc.NASDAQ:EPIXEPI-506 Phase 1 Provides Some POC But PK Hurdles Too HighBiotechnologyDownloadbiotechnology
09-12-2017Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-07-2017Concordia International Corp.NASDAQ: CXRX, TSX: CXRDELIVER Strategy UpdateSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-01-2017Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMSteadyMed Receives RTFSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-30-2017Prometic Life Sciences Inc.TSX:PLIRare Pediatric Disease Designation for PlasminogenBiotechnologyDownloadbiotechnology
08-29-2017CannTrust Holdings Inc.CSE:TRST2Q-2017 Financial ResultsMedical MarijuanaDownloadmedical-marijuana
08-18-2017CannTrust Holdings Inc.CSE:TRSTStrong Business Fundamentals, Nice ValuationMedical MarijuanaDownloadmedical-marijuana
08-17-2017BioSyent Inc.TSX-V:RX2Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-16-2017Prometic Life Sciences Inc.TSX:PLI2Q-2017 Financial ResultsBiotechnologyDownloadbiotechnology
08-14-2017Concordia International Corp.NASDAQ: CXRX, TSX: CXR2Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-14-2017Cipher Pharmaceuticals Inc.TSX:CPH2Q-2017 ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-11-2017Nuvo Pharmaceuticals Inc.TSX:NRI2Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-11-2017Knight Therapeutics Inc.TSX:GUD2Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-10-2017Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZ2Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-09-2017Novelion Therapeutics Inc.NASDAQ:NVLNNovelion Therapeutics Inc. (NASDAQ:NVLN; US$9.22)BiotechnologyDownloadbiotechnology
08-09-2017Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM2Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-04-2017Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
07-11-2017Script TrendsScript TrendsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-30-2017Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZBUY Thesis Starting to Play-outSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-28-2017Xenon Pharmaceuticals Inc.NASDAQ:XENESecond Failed Phase 2 – Darkest Before the Dawn?BiotechnologyDownloadbiotechnology
06-19-2017Novelion Therapeutics Inc.NASDAQ:NVLNResearch Initiation: Good Merger for Both SidesBiotechnologyDownloadbiotechnology
06-06-2017ESSA Pharma Inc.NASDAQ:EPIX6th Cohort Data Adds UncertaintyBiotechnologyDownloadbiotechnology
05-26-2017BioSyent Inc.TSX-V:RX1Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-18-2017ESSA Pharma Inc.NASDAQ:EPIXFirst Hints of EPI-506 Efficacy – More Data at ASCOBiotechnologyDownloadbiotechnology
05-16-2017Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM1Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-15-2017Nuvo Pharmaceuticals Inc.TSX:NRINear-Term Generic Risk Gone, but EU Opportunity Likely Gone TooSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-12-2017Nuvo Pharmaceuticals Inc.TSX:NRI1Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-12-2017Knight Therapeutics Inc.TSX:GUD1Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-12-2017Cipher Pharmaceuticals Inc.TSX:CPH1Q-2017 Results. Confluence of Positive Factors. Upgrading to BUYSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-11-2017Merus Labs International Inc.TSX:MSL; NASDAQ:MSLIMSL to be Acquired for C$1.65 per ShareSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-11-2017Concordia International Corp.NASDAQ: CXRX, TSX: CXR1Q-2017 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-10-2017Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZ1Q-2017 Results: Additional Steps to Reduce Costs Welcome; Success or Failure Still Hinges on ZontivitySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-09-2017Nuvo Pharmaceuticals Inc.TSX:NRIHorizon Sneezes – Nuvo Likely to Catch a ColdSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-27-2017Xenon Pharmaceuticals Inc.NASDAQ:XENEThe Zen of XEN1101BiotechnologyDownloadbiotechnology
04-10-2017Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZUpgrading ARLZ to BUY (Speculative) Following Sharp Sell-Off – Zontivity the Key Reason to Own at this LevelSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-07-2017Aurinia Pharmaceuticals Inc.NASDAQ:AUPHNo Extra Hurdles for International Approval of VoclosporinBiotechnologyDownloadbiotechnology
04-04-2017Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TREarly Phase 1b Highlights: First Complete Remission With TTI-621 Monotherapy; Signs of Efficacy in Combo With RituxanBiotechnologyDownloadbiotechnology
04-04-2017Cipher Pharmaceuticals Inc.TSX:CPHAmendment to Athyrium debt facilitySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-03-2017Prometic Life Sciences Inc.TSX:PLI4Q-2016 Financial ResultsBiotechnologyDownloadbiotechnology
03-31-2017Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMFlash: SteadyMed Favorable Ruling in Inter Partes ReviewSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-27-2017Xenon Pharmaceuticals Inc.NASDAQ:XENEXEN801 Fails Phase 2a Acne TrialBiotechnologyDownloadbiotechnology
03-16-2017Concordia International Corp.NASDAQ: CXRX, TSX: CXR4Q-2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-16-2017BioSyent Inc.TSX-V:RX4Q-2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-14-2017Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZ4Q-2016 Financial Results – Toprol Joins Yosprala as a Concern. Zoning in on ZontivitySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-08-2017Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM4Q-2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-03-2017Nuvo Pharmaceuticals Inc.TSX:NRI4Q-2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-03-2017Cipher Pharmaceuticals Inc.TSX:CPH4Q-16 ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-02-2017Aurinia Pharmaceuticals Inc.NASDAQ:AUPHAURA-LV Results Even Better at 48 WeeksBiotechnologyDownloadbiotechnology
03-01-2017Bellus Health Inc.NASDAQ:BLU; TSX: BLUBack in the SaddleBiotechnologyDownloadbiotechnology
02-16-2017Merus Labs International Inc.TSX:MSL; NASDAQ:MSLIFY1Q-17 ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-16-2017Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRPK/PD Boosts Possibility of Monotherapy ActivityBiotechnologyDownloadbiotechnology
02-13-2017Merus Labs International Inc.TSX:MSL; NASDAQ:MSLIExpected Product Erosions, Balance Sheet WeighSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-13-2017BioSyent Inc.TSX-V:RXStrong Record of Growth/Profitability Reflected in ValuationBiotechnologyDownloadbiotechnology
02-13-2017Cipher Pharmaceuticals Inc.TSX:CPHU.S. Stumble Likely Priced-inSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
01-20-2017Prometic Life Sciences Inc.TSX:PLIFDA Priority Review Voucher (PRV) for Plasminogen?BiotechnologyDownloadbiotechnology
01-09-2017Arbutus Biopharma CorporationNASDAQ: ABUSRating Upgrade – Get on the BUS!BiotechnologyDownloadbiotechnology
01-05-2017Prometic Life Sciences Inc.TSX:PLIProMetic Buys Back Plasminogen RightsBiotechnologyDownloadbiotechnology
01-04-2017Top Ideas2017 Top Ideas; Healthcare Sector Review/PreviewSector ReportsDownloadsector-reports
12-22-2016Xenon Pharmaceuticals Inc.NASDAQ:XENEResearch InitiationBiotechnologyDownloadbiotechnology
12-19-2016Prometic Life Sciences Inc.TSX:PLIBLA Filing for PlasminogenBiotechnologyDownloadbiotechnology
12-15-2016Knight Therapeutics Inc.TSX:GUDLicense Agreement for Movantik in Canada and IsraelSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-15-2016Knight Therapeutics Inc.TSX:GUDLicense Agreement for Movantik in Canada and IsraelSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-14-2016Arbutus Biopharma CorporationNASDAQ: ABUSAdditional Data from the ARB-1467 Phase 2 TrialBiotechnologyDownloadbiotechnology
12-05-2016Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRTTI-621 Phase 1a ResultsBiotechnologyDownloadbiotechnology
11-30-2016Prometic Life Sciences Inc.TSX:PLIMissing Patients and PBI-4050 StructureBiotechnologyDownloadbiotechnology
11-22-2016Prometic Life Sciences Inc.TSX:PLIAnalyst Day Recap. Valuation High and Balance Sheet Lite Ahead of Next Expected, Riskier Steps, in Our OpinionBiotechnologyDownloadbiotechnology
11-17-2016Prometic Life Sciences Inc.TSX:PLIEarly IPF Results – Look Similar to Early Esbriet Results. Catch-22?BiotechnologyDownloadbiotechnology
11-15-2016Prometic Life Sciences Inc.TSX:PLI3Q-2016 Financial ResultsBiotechnologyDownloadbiotechnology
11-14-2016Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRForty Seven’s Hu5F9-G4 Continues to Underwhelm as Monotherapy. Science, Risk/Reward Still Favor TRIL – Spec BUY if TRIL SellsBiotechnologyDownloadbiotechnology
11-14-2016Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRForty Seven’s Hu5F9-G4 Continues to Underwhelm as Monotherapy. Science, Risk/Reward Still Favor TRIL – Spec BUY if TRIL SellsBiotechnologyDownloadbiotechnology
11-11-2016Nuvo Pharmaceuticals Inc.TSX:NRI3Q-2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-10-2016Knight Therapeutics Inc.TSX:GUD3Q-2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-09-2016Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM3Q-2016 Financial Results. XYDALBA Soon LaunchingSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-08-2016Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZ3Q Beats Estimates. YOSPRALA Launch; Macro FactorsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-07-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXR3Q-2016 Financial Results. Throwing in the TowelSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-04-2016Aurinia Pharmaceuticals Inc.NASDAQ:AUPHWhen 1 is Better than 2BiotechnologyDownloadbiotechnology
11-04-2016Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRTomâto-Tomäto. Toxicity-Activity? We Think Buying OpportunityBiotechnologyDownloadbiotechnology
11-02-2016Nuvo Pharmaceuticals Inc.TSX:NRI3Q-2016 Preview. Scripts Down; Markman DecisionSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-27-2016Prometic Life Sciences Inc.TSX:PLIPlasminogen Meets Endpoints in Pivotal Phase2/3 TrialBiotechnologyDownloadbiotechnology
10-26-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXRCMA Investigating CXRX Drug Prices. 2nd Reading of Health Service Medical Supplies (Costs) Bill Faces Little ObjectionSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-21-2016Prometic Life Sciences Inc.TSX:PLIMore Data in Metabolic Syndrome and Type 2 DiabetesBiotechnologyDownloadbiotechnology
10-13-2016Prometic Life Sciences Inc.TSX:PLIEarly PBI-4050 Clinical Results in Alström SyndromeBiotechnologyDownloadbiotechnology
10-07-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXRHail MarySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-06-2016Arbutus Biopharma CorporationNASDAQ: ABUSAlnylam Terminates Revusiran. Good? Bad? For ABUS – We Think GoodBiotechnologyDownloadbiotechnology
10-06-2016Prometic Life Sciences Inc.TSX:PLIGood? Bad? Inconclusive? Upcoming Clinical ResultsBiotechnologyDownloadbiotechnology
10-05-2016Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZGrowing Into Its Market CapSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-03-2016Arbutus Biopharma CorporationNASDAQ: ABUSArbutus Reports Interim Data for ARB-1467BiotechnologyDownloadbiotechnology
10-03-2016Aurinia Pharmaceuticals Inc.NASDAQ:AUPHAdditional AURA-LV DetailsBiotechnologyDownloadbiotechnology
09-19-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXRProposed UK Health Service Medical Supplies (Costs) Bill Adds Substantial Risk to ConcordiaSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-16-2016Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZYOSPRALA Granted FDA ApprovalSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-08-2016Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZZONTIVITY Adds to Growing Cardiovascular BusinessSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-25-2016Prometic Life Sciences Inc.TSX:PLIAcquisition of TelestaBiotechnologyDownloadbiotechnology
08-18-2016Prometic Life Sciences Inc.TSX:PLIResearch Initiation. Fully Valued for Risk/RewardBiotechnologyDownloadbiotechnology
08-16-2016Aurinia Pharmaceuticals Inc.NASDAQ:AUPHAURA-LV – Complex Patients; Complex Trial; Complex Topline Results. Encouraging with WrinklesBiotechnologyDownloadbiotechnology
08-12-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXR2Q-2016 Financial Results. Soon to be a UnicycleSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-11-2016Nuvo Pharmaceuticals Inc.TSX:NRI2Q- 2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-11-2016Knight Therapeutics Inc.TSX:GUD2Q-2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-10-2016Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMCardiome – Second Quarter 2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-09-2016Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZ2Q Beats EstimatesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-08-2016Arbutus Biopharma CorporationNASDAQ: ABUSArbutus Trims Pipeline; Provides Corporate UpdateBiotechnologyDownloadbiotechnology
07-26-2016ESSA Pharma Inc.NASDAQ:EPIXCompetitor Fails in Phase 3BiotechnologyDownloadbiotechnology
07-26-2016Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMPunishing Financing for Current ShareholdersSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-24-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXRBrexit Vote Adds Headwinds and UncertaintySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-20-2016Nuvo Pharmaceuticals Inc.TSX:NRIInitiation – Flipping the Switch to Positive Cash FlowSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-20-2016Bellus Health Inc.NASDAQ:BLU; TSX: BLUKiacta Fails in Phase 3 AA Amyloidosis StudyBiotechnologyDownloadbiotechnology
06-08-2016Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRCompetitor’s “Anemic” Data Increases TRIL Risk/RewardBiotechnologyDownloadbiotechnology
06-02-2016Knight Therapeutics Inc.TSX:GUD1Q-2016 Financial Results and Subsequent EventsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
06-02-2016CRH Medical Corp.NYSE MKT:CRHM, TSX:CRHCRH Acquires Majority Stake in AGAAHealthcare ServicesDownloadhealthcare-services
05-19-2016Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRASCO Abstracts – No CD47 Fireworks, But Class-Leading Potential for TTI-621 Gains a Bit More SupportBiotechnologyDownloadbiotechnology
05-16-2016Aurinia Pharmaceuticals Inc.NASDAQ:AUPHAdditional AURION ResultsBiotechnologyDownloadbiotechnology
05-16-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXR1Q-2016 Revenues, EBITDA Beat. Some Gives and TakesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-16-2016Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMCardiome – First Quarter 2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-11-2016Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZ1Q Below Estimates – Near-term Events Expected to Drive StockSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-09-2016Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMXYDALBA Moves Cardiome to the Next LevelSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-29-2016CRH Medical Corp.NYSE MKT:CRHM, TSX:CRHQ1-2016 Results – Strong Top Line; Lower MarginsHealthcare ServicesDownloadhealthcare-services
04-27-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXRValuing Potential OutcomesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-26-2016Knight Therapeutics Inc.TSX:GUDKnight Receives Health Canada NOD for Atryn; Signs Neuragen Commercial Partner for the Middle EastSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-26-2016Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZHealth Canada Approves BLEXTENSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-22-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXRMuch Ado About Something? PE Interest Makes Sense to UsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-15-2016Knight Therapeutics Inc.TSX:GUDA Deeper DiveSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-28-2016Knight Therapeutics Inc.TSX-V:GUDFourth Quarter 2015 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-28-2016Concordia International Corp.NASDAQ: CXRX, TSX: CXR4Q-2015 Results Mixed. Value Opportunity IntactSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-28-2016Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZPublishing Updated ForecastsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-17-2016Knight Therapeutics Inc.TSX:GUD4Q-2016 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-10-2016Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM4Q-2015 Light, But Relevance LowSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-09-2016Aralez Pharmaceuticals Inc.NASDAQ:ARLZ; TSX:ARZBirth of a Diversified, Well-Capitalized Specialty Pharma Company With Multiple Near-Term Inflection PointsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-26-2016CRH Medical Corp.NYSE MKT:CRHM, TSX:CRHGenerally In-Line 4Q Caps a Transformative 2015Healthcare ServicesDownloadhealthcare-services
02-13-2016Industry OverviewIntroductionSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-08-2016Aurinia Pharmaceuticals Inc.NASDAQ:AUPHEarly AURION Results Potentially Positive for AURA-LVBiotechnologyDownloadbiotechnology
02-03-2016Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRFirst Patient DosedBiotechnologyDownloadbiotechnology
01-28-2016Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMOrphan Drug Application Filed for Oral VernkalantBiotechnologyDownloadbiotechnology
01-28-2016Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRBuys Drug Discovery Platform – Potential to Expand Immuno-oncology Portfolio; Monetize Other ProgramsBiotechnologyDownloadbiotechnology
01-25-2016Bellus Health Inc.NASDAQ:BLU; TSX: BLUAnother Important Countdown BeginsBiotechnologyDownloadbiotechnology
01-22-2016Aurinia Pharmaceuticals Inc.NASDAQ:AUPHCountdown BeginsBiotechnologyDownloadbiotechnology
01-19-2016ESSA Pharma Inc.NASDAQ:EPIXResearch Initiation – Validated Drug Target, Funded to a Potential Near-Term $1 B Liquidity EventBiotechnologyDownloadbiotechnology
01-04-2016Top Ideas2016 Top Ideas: CRH and Basket of Small Cap BiotechsSector ReportsDownloadsector-reports
12-14-2015CRH Medical Corp.TSX:CRH, NASDAQ:CRHMBringing Home the MaconHealthcare ServicesDownloadhealthcare-services
12-08-2015CRH Medical Corp.TSX:CRH, NASDAQ:CRHMGeorgia on My Mind – GAA Visit Strengthens BUY ThesisHealthcare ServicesDownloadhealthcare-services
11-25-2015CRH Medical Corp.TSX:CRH, NASDAQ:CRHMCRH Secures New Debt With Lower Interest RateHealthcare ServicesDownloadhealthcare-services
11-12-2015Knight Therapeutics Inc.TSX-V:GUDThird Quarter 2015 Financial ResultsSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-12-2015Concordia International Corp.NASDAQ: CXRX, TSX: CXR3Q-2015 Financial Results. Our Initial TakeSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
11-09-2015Canadian Healthcare SectorCanadian Healthcare SectorSector ReportsDownloadsector-reports
11-09-2015CRH Medical Corp.TSX:CRH, NASDAQ:CRHMCMS Final Rule – Anesthesia Reimbursement Unchanged in 2016. Looking AheadHealthcare ServicesDownloadhealthcare-services
10-30-2015CRH Medical Corp.TSX:CRH, NASDAQ:CRHMThird Quarter 2015 ResultsHealthcare ServicesDownloadhealthcare-services
10-27-2015Concordia International Corp.NASDAQ: CXRX, TSX: CXRPreliminary 2016 GuidanceSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-12-2015Concordia International Corp.NASDAQ: CXRX, TSX: CXRConcordia Discloses Maximum Debt Rate of 7.25%Specialty PharmaceuticalDownloadspecialty-pharmaceutical
10-09-2015Arbutus Biopharma CorporationNASDAQ:ABUSDon’t Write-off the BUSBiotechnologyDownloadbiotechnology
10-07-2015Knight Therapeutics Inc.TSX-V:GUDAdvaxis Lead Program Placed on Clinical HoldSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
10-05-2015Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRReducing Target Price Based on Lower Comps, but Increasing Rating to BUY Due to Stock PullbackBiotechnologyDownloadbiotechnology
09-28-2015Concordia International Corp.NASDAQ: CXRX, TSX: CXRUnfortunate TimingSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-11-2015CRH Medical Corp.TSX:CRH, NASDAQ:CRHMCRH Keeps it Rollin’ with Second Transaction in a MonthHealthcare ServicesDownloadhealthcare-services
09-09-2015Concordia International Corp.NASDAQ: CXRX, TSX: CXRConcordia Gains International Footprint with AMCo BuySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
09-01-2015Knight Therapeutics Inc.TSX:GUDBig Step in Molding Knight’s FutureSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-26-2015Knight Therapeutics Inc.TSX-V:GUDPre-Phase 3 Cancer Immunotherapy Licensing DealSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-19-2015CRH Medical Corp.TSX:CRH,Incremental Acquisition Bumps Target Price to $5.90Healthcare ServicesDownloadhealthcare-services
08-17-2015Concordia International Corp.NASDAQ: CXRX, TSX: CXR2Q-2015 Financials In-Line. M&A Remains Key DriverSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-13-2015Knight Therapeutics Inc.TSX-V:GUD2Q Review – Good Income from Investing/Lending Strategy; Pipeline Build ContinuesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
08-05-2015Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM2Q-2015 ResultsBiotechnologyDownloadbiotechnology
07-30-2015CRH Medical Corp.TSX:CRH2Q-2015 ResultsHealthcare ServicesDownloadhealthcare-services
07-23-2015Knight Therapeutics Inc.TSX-V:GUDIt’s Been a Busy Knight (including company’s first fundsourced product deal)Specialty PharmaceuticalDownloadspecialty-pharmaceutical
06-23-2015Tekmira Pharmaceuticals CorporationNASDAQ:TKMRTKM-Ebola-Guinea Trial FailsBiotechnologyDownloadbiotechnology
06-11-2015Trillium Therapeutics Inc.NASDAQ:TRIL, TSX:TRIncreasing Target Price but Reducing Rating Due to Stock AppreciationBiotechnologyDownloadbiotechnology
06-08-2015CRH Medical Corp.TSX:CRHResearch Initiation – Attractive Healthcare Roll-up OpportunityHealthcare ServicesDownloadhealthcare-services
05-27-2015Concordia International Corp.TSX: CXRManagement, Board Changes. Proposed FTC Settlement NegotiatedSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-26-2015Concordia International Corp.TSX: CXRPlaquenil Market Undergoing Major Shift – Concordia’s Authorized Generic a Leading BeneficiarySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-22-2015Tribute Pharmaceuticals Canada Inc.TSX-V: TRXU.S. Expansion Initiated with Small AcquisitionSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-19-2015Concordia International Corp.NASDAQ: CXRX, TSX: CXR1Q-2015 Below Estimates on Donnatal De-Stocking; SHDSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-15-2015Knight Therapeutics Inc.TSX-V:GUDCheap Product Deals Remain Elusive for Now; 1Q-2015 Financial Results Show Upside to Loan StrategySpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-13-2015Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMMixed 1Q-2015 Results; New Product Licensed; Waiting on FDABiotechnologyDownloadbiotechnology
05-13-2015Tribute Pharmaceuticals Canada Inc.TSX-V: TRX1Q-2015 Financial Results In Line – Growth ContinuesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
05-12-2015Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM1Q-2015 Financial Results PreviewBiotechnologyDownloadbiotechnology
04-27-2015Concordia International Corp.NASDAQ: CXRX, TSX: CXR1Q-2015 Financial Results PreviewSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
04-09-2015Tekmira Pharmaceuticals CorporationNASDAQ:TKMRResearch Initiation – Many Shots on GoalBiotechnologyDownloadbiotechnology
03-23-2015Concordia International Corp.TSX: CXR4Q-2014 Achieves Top End of Recent GuidanceSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-20-2015Knight Therapeutics Inc.TSX-V:GUD4Q-2014 In LineSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-12-2015Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM4Q-2014 LightBiotechnologyDownloadbiotechnology
03-10-2015Concordia International Corp.TSX: CXRBig Accretive Acquisition Bumps Target Price AgainSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
03-04-2015Tribute Pharmaceuticals Canada Inc.TSX-V: TRX4Q-2014 in line. Early signs investment is paying offSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
02-09-2015Aurinia Pharmaceuticals Inc.NASDAQ:AUPHInitiation of AURION StudyBiotechnologyDownloadbiotechnology
01-27-2015Tribute Pharmaceuticals Canada Inc.TSX-V: TRXKey Growth Drivers Making an Impact. Overall Q4-2014 Revenue Guidance Base Slightly Below EstimatesSpecialty PharmaceuticalDownloadspecialty-pharmaceutical
12-18-2014Healthcare Sector OverviewResearch Initiation – Healthcare Sector OverviewBiotechnology, Specialty PharmaceuticalDownloadbiotechnology specialty-pharmaceutical
03-13-2014DISCONTINUED RESEARCHDiscontinuing research coverageBiotechnologyDownloadbiotechnology
03-03-2014PALADIN LABS INC.TSX:PLBDiscontinuing research coverageBiotechnologyDownloadbiotechnology
02-28-2014Transition Therapeutics Inc.TSX:TTH, Q:TTHITTH reclaims ELND005 rights and benefits associated with Irishdomiciled subsidiary. Increasing price target to $7.00BiotechnologyDownloadbiotechnology
02-27-2014Theratechnologies Inc.TSX:THF2013 results reported. No answers yet on Egrifta supply issuesBiotechnologyDownloadbiotechnology
02-21-2014Nuvo Research Inc.TSX:NRI2013 results leave us concerned about strength of balance sheetBiotechnologyDownloadbiotechnology
02-20-2014Trimel Pharmaceuticals Inc.TSX:TRL$10.5 million private placement adds a cash cushion while we wait for an FDA responseBiotechnologyDownloadbiotechnology
02-20-2014Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMCRME capitalizes on attractive share price and raises C$15 millionBiotechnologyDownloadbiotechnology
02-18-2014Theratechnologies Inc.TSX:THDowngrading to Sell on continued manufacturing issues and stockouts; price target to $0.30BiotechnologyDownloadbiotechnology
02-18-2014Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM“At the market” offering to bolster the balance sheetBiotechnologyDownloadbiotechnology
02-13-2014Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ2 F2014 results as expected. New compound expected to be inlicensed soonBiotechnologyDownloadbiotechnology
01-27-2014QLT INC.NASDAQ: QLTI; TSX:QLTRe-treatment data from QLT091001 too preliminary for any conclusionsBiotechnologyDownloadbiotechnology
01-23-2014QLT INC.NASDAQ: QLTI; TSX:QLTRaising price target to $7.50 for upside re potential sale of businessBiotechnologyDownloadbiotechnology
01-17-2014Nuvo Research Inc.TSX:NRIPennsaid 2% approved; now we wait for sales numbersBiotechnologyDownloadbiotechnology
01-17-2014Trimel Pharmaceuticals Inc.TSX:TRLCompleoTRT PDUFA date pushed back to May 28, 2014BiotechnologyDownloadbiotechnology
01-10-2014CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH2013 revenues expected to be $7.68 million. Price target reverts back to $0.70BiotechnologyDownloadbiotechnology
01-10-2014CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH2013 revenues expected to be $7.86 million. Upping price target to $0.80BiotechnologyDownloadbiotechnology
01-09-2014Æterna Zentaris Inc.Q:AEZS; TSX:AEZAEZS raises $13.2 million less than 2 months after last raiseBiotechnologyDownloadbiotechnology
01-06-2014Canadian HealthcareNavigating the Canadian Biotech SpaceBiotechnologyDownloadbiotechnology
12-20-2013Trimel Pharmaceuticals Inc.TSX:TRLTRL elects to pursue only three times daily dosing for CompleoTRT. Lowering price target to $0.75 and rating to HoldBiotechnologyDownloadbiotechnology
12-13-2013Theratechnologies Inc.TSX:THTH regains U.S Egrifta rights at a cost of US$20 million + royalties. Rating to Hold; price target to $0.50BiotechnologyDownloadbiotechnology
12-11-2013PALADIN LABS INC.TSX:PLBMore details about PLB acquisition revealed in Proxy StatementBiotechnologyDownloadbiotechnology
11-26-2013PALADIN LABS INC.TSX:PLBWho is the most likely purchaser of a priority review voucher?BiotechnologyDownloadbiotechnology
11-21-2013QLT INC.NASDAQ: QLTI; TSX:QLTQLTI evaluating strategic alternatives. Pivotal retinoid program could start in H1 2014BiotechnologyDownloadbiotechnology
11-21-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYPhase III head & neck data doesn’t shed much light, in our viewBiotechnologyDownloadbiotechnology
11-20-2013Æterna Zentaris Inc.Q:AEZS; TSX:AEZAEZS once again taps the market for more cashBiotechnologyDownloadbiotechnology
11-19-2013Oncolytics Biotech Inc.NASDAQ: OGXISYNERGY trial continues after interim analysisBiotechnologyDownloadbiotechnology
11-19-2013Cardiome Pharma Corp.NASDAQ:CRME, TSX:COMCRME transforms itself with acquisition of Correvio. Price target upped to $3.25BiotechnologyDownloadbiotechnology
11-14-2013PALADIN LABS INC.TSX:PLBQ3 2013 results not as important now that PLB is expected to be acquiredBiotechnologyDownloadbiotechnology
11-13-2013Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ1 F2014 results in line. Waiting for news from partners’ clinical development activitiesBiotechnologyDownloadbiotechnology
11-12-2013PALADIN LABS INC.TSX:PLBFDA review of Impavido extended by three monthsBiotechnologyDownloadbiotechnology
11-08-2013Oncogenex Pharmaceuticals Inc.NASDAQ: OGXISYNERGY phase III results still expected mid-2014BiotechnologyDownloadbiotechnology
11-07-2013QLT INC.NASDAQ: QLTI; TSX:QLTQ3 2013 results. Waiting for strategy for QLT091001BiotechnologyDownloadbiotechnology
11-07-2013Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMCRME working hard to realize Brinavess potentialBiotechnologyDownloadbiotechnology
11-07-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ3 2013 results show no surprisesBiotechnologyDownloadbiotechnology
11-06-2013Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ3 2013 results favourably impacted by acceleration of Cetrotide deferred revenueBiotechnologyDownloadbiotechnology
11-05-2013PALADIN LABS INC.TSX:PLBPALADIN LABS INC. (TSX:PLB; $62.98)BiotechnologyDownloadbiotechnology
11-04-2013Trimel Pharmaceuticals Inc.TSX:TRLQ3 2013 results. Scenario analysis for CompleoTRT. Lowering target to $1.50BiotechnologyDownloadbiotechnology
11-04-2013Theratechnologies Inc.TSX:THHealth Canada to resume tesamorelin reviewBiotechnologyDownloadbiotechnology
10-31-2013Nuvo Research Inc.TSX:NRIQ3 2013 results affected by one-time items. Decision on Pennsaid 2% next major eventBiotechnologyDownloadbiotechnology
10-29-2013CRH Medical Corp.TSX:CRHQ3 2013 financials in lineBiotechnologyDownloadbiotechnology
10-28-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYONC highlights NSCLC dataBiotechnologyDownloadbiotechnology
10-25-2013Trimel Pharmaceuticals Inc.TSX:TRLTRL faces its own FDA stumbling block. Partnering delays likely. Price target lowered to $2.00BiotechnologyDownloadbiotechnology
10-24-2013Trimel Pharmaceuticals Inc.TSX:TRLDevelopment of a CompleoTRT competitor hits a speed bumpBiotechnologyDownloadbiotechnology
10-23-2013Trimel Pharmaceuticals Inc.TSX:TRLDevelopment of a CompleoTRT competitor hits a speed bumpBiotechnologyDownloadbiotechnology
10-18-2013PALADIN LABS INC.TSX:PLBFDA advisory committee votes in favour of ImpavidoBiotechnologyDownloadbiotechnology
10-16-2013PALADIN LABS INC.TSX:PLBFDA publishes Impavido advisory committee briefing documentsBiotechnologyDownloadbiotechnology
10-10-2013Theratechnologies Inc.TSX:THQ3 F2013 expenses high as TH tackles manufacturing issuesBiotechnologyDownloadbiotechnology
10-01-2013CML Healthcare Inc.TSX:CLCDiscontinuing research coverageBiotechnologyDownloadbiotechnology
10-01-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYMore Reolysin data, but not what we’re waiting forBiotechnologyDownloadbiotechnology
09-23-2013Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMCRME stock surging; awaiting H2 results to see vernakalant salesBiotechnologyDownloadbiotechnology
09-19-2013Theratechnologies Inc.TSX:THManufacturing issues continue to impact Egrifta®BiotechnologyDownloadbiotechnology
09-18-2013Medicago Inc.TSX:MDGDiscontinuing research coverageBiotechnologyDownloadbiotechnology
09-12-2013Transition Therapeutics Inc.TSX:TTH, Q:TTHIF2013 results reported. Product development continuing as expectedBiotechnologyDownloadbiotechnology
09-09-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYFinal lung cancer tumour response data consistent with earlier reportsBiotechnologyDownloadbiotechnology
08-26-2013Trimel Pharmaceuticals Inc.TSX:TRLInitiating coverage with a Buy rating and C$2.25 targetBiotechnologyDownloadbiotechnology
08-21-2013Nuvo Research Inc.TSX:NRINRI fights backBiotechnologyDownloadbiotechnology
08-14-2013PALADIN LABS INC.TSX:PLBUpping price target to $61.00 due to strong business performance and rising sector multiplesBiotechnologyDownloadbiotechnology
08-09-2013Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIR&D spend rising in Q2 to support development. Custirsen phase III data pushed back to mid-2014BiotechnologyDownloadbiotechnology
08-09-2013CML Healthcare Inc.TSX:CLCOn track for acquisition by LifelabsBiotechnologyDownloadbiotechnology
08-09-2013Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ2 2013 results impacted by acceleration of Cetrotide deferred revenue. Moving towards being a commercial companyBiotechnologyDownloadbiotechnology
08-06-2013Transition Therapeutics Inc.TSX:TTH, Q:TTHITTH raises US$11 million in private placementBiotechnologyDownloadbiotechnology
08-02-2013QLT INC.NASDAQ: QLTI; TSX:QLTLowering price target to $5.50 and rating to Hold post shareholder payoutBiotechnologyDownloadbiotechnology
08-02-2013Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMQ2 2013 results show rising costs to support Brinavess salesBiotechnologyDownloadbiotechnology
08-01-2013Nuvo Research Inc.TSX:NRIQ2 2013 results show weak Pennsaid sales. Strategy shifts to WF-10BiotechnologyDownloadbiotechnology
08-01-2013QLT INC.NASDAQ: QLTI; TSX:QLTQ2 2013 results. Waiting for QLT091001 development planBiotechnologyDownloadbiotechnology
08-01-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ2 2013 results. Scenario analysis for ReolysinBiotechnologyDownloadbiotechnology
07-25-2013Æterna Zentaris Inc.Q:AEZS; TSX:AEZAEZS raises $7.8 million. Lowering price target to $0.75BiotechnologyDownloadbiotechnology
07-24-2013Transition Therapeutics Inc.TSX:TTH, Q:TTHIDéjà vu – TTH and LLY partner up againBiotechnologyDownloadbiotechnology
07-23-2013CRH Medical Corp.TSX:CRHQ2 2013 financials in line with estimatesBiotechnologyDownloadbiotechnology
07-22-2013Nuvo Research Inc.TSX:NRIUpdate on NRI after licensing U.S. Synera rightsBiotechnologyDownloadbiotechnology
07-22-2013Medicago Inc.TSX:MDGIncreasing price target to $1.16 due to Mitsubishi Tanabe Pharma proposed acquisitionBiotechnologyDownloadbiotechnology
07-10-2013Theratechnologies Inc.TSX:THU.S. Egrifta sales in Q2 F2013 improved over previous year but flat sequentiallyBiotechnologyDownloadbiotechnology
07-03-2013Canadian HealthcareNavigating the Canadian Biotech SpaceBiotechnologyDownloadbiotechnology
06-25-2013CML Healthcare Inc.TSX:CLCCLC to be acquired for $10.75 per shareBiotechnologyDownloadbiotechnology
06-17-2013Transition Therapeutics Inc.TSX:TTH, Q:TTHILilly opts to develop TT-401. Price target upped to $3.50BiotechnologyDownloadbiotechnology
06-06-2013Medicago Inc.TSX:MDGMDG announces positive H7N9 preclinical dataBiotechnologyDownloadbiotechnology
06-06-2013PALADIN LABS INC.TSX:PLB“Bank of Paladin” makes two more investmentsBiotechnologyDownloadbiotechnology
06-05-2013Medicago Inc.TSX:MDGRating lowered to Hold on share price appreciation; we await outcome of pharma negotiationsBiotechnologyDownloadbiotechnology
05-16-2013Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMUpdate post Q1 2013 resultsBiotechnologyDownloadbiotechnology
05-13-2013Medicago Inc.TSX:MDGQ1 2013 results slightly ahead of our estimates. Future depends on signing lucrative contractsBiotechnologyDownloadbiotechnology
05-09-2013Nuvo Research Inc.TSX:NRI65:1 share consolidationBiotechnologyDownloadbiotechnology
05-09-2013PALADIN LABS INC.TSX:PLBQ1 2013 results appear solid. Upping target to $52 but lowering rating to Hold due to recent share price gainsBiotechnologyDownloadbiotechnology
05-09-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ1 2013 results. Reolysin survival data now predicted for H2BiotechnologyDownloadbiotechnology
05-08-2013CML Healthcare Inc.TSX:CLCQ1 2013 financials lower than consensus; CLC laying the groundwork for the futureBiotechnologyDownloadbiotechnology
05-08-2013Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ1 2013 results impacted by one-time non-cash itemsBiotechnologyDownloadbiotechnology
05-08-2013Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ3 F2013 financial results as expected. Waiting for a decision on TT401BiotechnologyDownloadbiotechnology
05-03-2013Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIRaising target to $25.00 on back of Q1 cost efficienciesBiotechnologyDownloadbiotechnology
05-03-2013PALADIN LABS INC.TSX:PLBQ1 2013 PreviewBiotechnologyDownloadbiotechnology
05-02-2013Nuvo Research Inc.TSX:NRIA disappointing start to the year. Expect a challenging year aheadBiotechnologyDownloadbiotechnology
05-02-2013QLT INC.NASDAQ: QLTI; TSX:QLTQ1 2013 financials show cost savings from restructuringBiotechnologyDownloadbiotechnology
05-01-2013CML Healthcare Inc.TSX:CLCWestern expansion with small acquisitionBiotechnologyDownloadbiotechnology
04-30-2013Transition Therapeutics Inc.TSX:TTH, Q:TTHIEarly TT-401 data look promisingBiotechnologyDownloadbiotechnology
04-25-2013Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMBrinavess rights transitioned back to CardiomeBiotechnologyDownloadbiotechnology
04-24-2013CRH Medical Corp.TSX:CRHQ1 2013 financials mostly in line. Lowering rating to Hold due to implied return to targetBiotechnologyDownloadbiotechnology
04-18-2013Medicago Inc.TSX:MDGIDRI phase I H5N1 vaccine results positive; new adjuvant not betterBiotechnologyDownloadbiotechnology
04-15-2013QLT INC.NASDAQ: QLTI; TSX:QLTQLTI proposes tax-efficient $200 million cash distribution to shareholdersBiotechnologyDownloadbiotechnology
04-15-2013Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM5:1 share consolidation to gain NASDAQ complianceBiotechnologyDownloadbiotechnology
04-11-2013Theratechnologies Inc.TSX:THQ1 F2013 results show profit due to lease renegotiation. Manufacturing QA issues arise. Production suspendedBiotechnologyDownloadbiotechnology
04-10-2013Æterna Zentaris Inc.Q:AEZS; TSX:AEZAgreement with Ergomed to share costs of AEZS-108 phase III trialBiotechnologyDownloadbiotechnology
04-09-2013Medicago Inc.TSX:MDGWhat we’re looking for in April 17th IDRI pandemic flu resultsBiotechnologyDownloadbiotechnology
04-08-2013Theratechnologies Inc.TSX:THFerrer hands back Egrifta®BiotechnologyDownloadbiotechnology
04-08-2013CML Healthcare Inc.TSX:CLCAutomation of microbiology analyses to increase efficiencyBiotechnologyDownloadbiotechnology
04-03-2013CML Healthcare Inc.TSX:CLCCML Healthcare – Diagnosis: On the road to recoveryBiotechnologyDownloadbiotechnology
04-01-2013Medicago Inc.TSX:MDG2012 results show high expense levelBiotechnologyDownloadbiotechnology
03-28-2013Nuvo Research Inc.TSX:NRIQ4 2012 Pennsaid sales disappointing. Lowering target to $0.05 given our 2013 outlookBiotechnologyDownloadbiotechnology
03-22-2013Æterna Zentaris Inc.Q:AEZS; TSX:AEZ2013 could be a challenging year with few value-inflection points. Lowering price target to $1.50BiotechnologyDownloadbiotechnology
03-21-2013CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH2012 financial results no surprisesBiotechnologyDownloadbiotechnology
03-20-2013Cardiome Pharma Corp.NASDAQ:CRME; TSX:COM2012 results. Can CRME be more successful than big pharma with direct sales of Brinavess?BiotechnologyDownloadbiotechnology
03-20-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYCompetitor oncolytic virus gets positive results in melanomaBiotechnologyDownloadbiotechnology
03-14-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCY2012 results: Don’t expect controlled Reolysin data until H2 2013BiotechnologyDownloadbiotechnology
03-11-2013Æterna Zentaris Inc.Q:AEZS; TSX:AEZPerifosine fails again in phase III trialBiotechnologyDownloadbiotechnology
03-08-2013Oncogenex Pharmaceuticals Inc.NASDAQ: OGXI2012 results show OGX-427 R&D spend high. Key year aheadBiotechnologyDownloadbiotechnology
03-05-2013Nuvo Research Inc.TSX:NRIPennsaid 2% gets FDA Complete Response LetterBiotechnologyDownloadbiotechnology
03-04-2013Theratechnologies Inc.TSX:THEgrifta® rejected by Health CanadaBiotechnologyDownloadbiotechnology
03-04-2013Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMSettlement of debt and launch of salesforceBiotechnologyDownloadbiotechnology
02-28-2013PALADIN LABS INC.TSX:PLB2012 results impacted by integration costs. PLB well positioned for 2013 and beyondBiotechnologyDownloadbiotechnology
02-27-2013Theratechnologies Inc.TSX:THF2012 results impacted by restructuring chargesBiotechnologyDownloadbiotechnology
02-25-2013QLT INC.NASDAQ: QLTI; TSX:QLT2012 results ahead of estimates due to low R&DBiotechnologyDownloadbiotechnology
02-21-2013PALADIN LABS INC.TSX:PLBErratum: Q4 and 2012 PreviewBiotechnologyDownloadbiotechnology
02-20-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYONC raises US$32 million in equity offering to bolster balance sheetBiotechnologyDownloadbiotechnology
02-20-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYRaising capital ahead of head & neck cancer dataBiotechnologyDownloadbiotechnology
02-14-2013Æterna Zentaris Inc.Q:AEZS; TSX:AEZPossible outcomes from perifosine interim analysisBiotechnologyDownloadbiotechnology
02-11-2013YM Biosciences Inc.TSX:YM; AMEX:YMIDiscontinuing research coverageBiotechnologyDownloadbiotechnology
02-08-2013Transition Therapeutics Inc.TSX:TTH, Q:TTHITT401/402 data expected in Q2; financial results as expectedBiotechnologyDownloadbiotechnology
02-08-2013Oncolytics Biotech Inc.TSX:ONC; Q:ONCYAdditional interim phase II lung data supports previous resultsBiotechnologyDownloadbiotechnology
01-29-2013Nuvo Research Inc.TSX:NRIPennsaid generic risk mitigated in the short-termBiotechnologyDownloadbiotechnology
01-28-2013Medicago Inc.TSX:MDGMDG enters into plant production collaborationBiotechnologyDownloadbiotechnology
01-28-2013QLT INC.NASDAQ: QLTI; TSX:QLTInitation of retinoid phase III trials delayed as QLTI seeks FDA inputBiotechnologyDownloadbiotechnology
01-17-2013Medicago Inc.TSX:MDGMDG raises $15 million in non-dilutive loanBiotechnologyDownloadbiotechnology
01-17-2013PALADIN LABS INC.TSX:PLBPrice target increased to $51.00; expecting another year of growthBiotechnologyDownloadbiotechnology
01-15-2013Diagnocure Inc.TSX:CURDiscontinuing research coverageBiotechnologyDownloadbiotechnology
01-15-2013CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH2012 revenues expected at $6.85 million. Lowering price target to $0.50BiotechnologyDownloadbiotechnology
01-03-2013Canadian HealthcareNavigating the Canadian Biotech SpaceBiotechnologyDownloadbiotechnology
12-24-2012QLT INC.NASDAQ: QLTI; TSX:QLTOption agreement reached on sale of punctal plug. Lowering target to $9.00BiotechnologyDownloadbiotechnology
12-18-2012Oncolytics Biotech Inc.TSX:ONC; Q:ONCYLowering rating to Hold after favourable reaction to interim Reolysin dataBiotechnologyDownloadbiotechnology
12-17-2012YM Biosciences Inc.TSX:YM; AMEX:YMIUpdated rating and price target post Gilead acquisitionBiotechnologyDownloadbiotechnology
12-10-2012YM Biosciences Inc.TSX:YM; AMEX:YMIUpdated CYT387 data presented at ASH 2012BiotechnologyDownloadbiotechnology
12-06-2012QLT INC.NASDAQ: QLTI; TSX:QLTAdditional restructuring and job losses at QLTIBiotechnologyDownloadbiotechnology
12-04-2012YM Biosciences Inc.TSX:YM; AMEX:YMILosing nimo: YM divests the asset. Stage set for CYT387 developmentBiotechnologyDownloadbiotechnology
11-20-2012PALADIN LABS INC.TSX:PLBStart of Latin American expansion with Ativa Pharma investment.BiotechnologyDownloadbiotechnology
11-15-2012Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMFuture remains uncertain. Lowering rating to Sell, price target to $0.10BiotechnologyDownloadbiotechnology
11-14-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ3 2012 results. Multiple myeloma interim data the key next stepBiotechnologyDownloadbiotechnology
11-13-2012PALADIN LABS INC.TSX:PLBOne-time Litha-related charges favourably impact Q3 results. Target lowered to $46.00BiotechnologyDownloadbiotechnology
11-12-2012Medicago Inc.TSX:MDGQ3 results reveal temporary delays in development.BiotechnologyDownloadbiotechnology
11-12-2012YM Biosciences Inc.TSX:YM; AMEX:YMINo surprises in Q1 F2013 resultsBiotechnologyDownloadbiotechnology
11-08-2012Oncogenex Pharmaceuticals Inc.NASDAQ: OGXILarge increase in R&D spend impacts Q3 2012 resultsBiotechnologyDownloadbiotechnology
11-08-2012Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ1 F2013 results in lineBiotechnologyDownloadbiotechnology
11-08-2012Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ3 2012 EPS ($0.12); we wait for Reolysin resultsBiotechnologyDownloadbiotechnology
11-07-2012QLT INC.NASDAQ: QLTI; TSX:QLTRestructuring charges impact Q3 2012. Focus on retinoid programBiotechnologyDownloadbiotechnology
11-05-2012YM Biosciences Inc.TSX:YM; AMEX:YMIASH 2012 abstract provides little additional data. Wait for December presentationBiotechnologyDownloadbiotechnology
11-01-2012Nuvo Research Inc.TSX:NRIQ3 2012 results disappoint. Potential for a generic Pennsaid any day. Lowering price target to $0.07BiotechnologyDownloadbiotechnology
10-30-2012Theratechnologies Inc.TSX:TH; Q:THERStormy times continue…updated strategic plan cuts more staffBiotechnologyDownloadbiotechnology
10-25-2012QLT INC.NASDAQ: QLTI; TSX:QLTPunctal plug data show improved retention over previous resultsBiotechnologyDownloadbiotechnology
10-22-2012Nuvo Research Inc.TSX:NRIPliaglis® approved by FDABiotechnologyDownloadbiotechnology
10-18-2012Medicago Inc.TSX:MDGCompetitor reports favourable phase I H5N1 flu vaccine resultsBiotechnologyDownloadbiotechnology
10-12-2012Theratechnologies Inc.TSX:TH; Q:THERCEO departs; new business plan in developmentBiotechnologyDownloadbiotechnology
10-12-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZ$16.5 million raise provides more capital but at significant dilutionBiotechnologyDownloadbiotechnology
10-10-2012Theratechnologies Inc.TSX:TH; Q:THERUpdate on Egrifta® regulatory issues; no major changesBiotechnologyDownloadbiotechnology
10-09-2012CRH Medical Corp.TSX:CRHQ3 2012 results in line. Waiting to see impact of top-line focusBiotechnologyDownloadbiotechnology
10-04-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZ6:1 share consolidation to regain compliance with NASDAQBiotechnologyDownloadbiotechnology
10-02-2012QLT INC.NASDAQ: QLTI; TSX:QLTShare repurchase plan announcedBiotechnologyDownloadbiotechnology
09-26-2012Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMMRK hands back vernakalant rightsBiotechnologyDownloadbiotechnology
09-25-2012Medicago Inc.TSX:MDGChinese rights to flu vaccine licensed to Philip MorrisBiotechnologyDownloadbiotechnology
09-24-2012YM Biosciences Inc.TSX:YM; AMEX:YMIAwaiting either a partner or the start of phase III trialsBiotechnologyDownloadbiotechnology
09-24-2012QLT INC.NASDAQ: QLTI; TSX:QLTSale of Visudyne® to Valeant; strategic plan on trackBiotechnologyDownloadbiotechnology
09-14-2012Transition Therapeutics Inc.TSX:TTH, Q:TTHIF2012 costs under control. Increasing price target to $2.50BiotechnologyDownloadbiotechnology
09-12-2012Oncolytics Biotech Inc.TSX:ONC; Q:ONCYLike waiting for Godot…still no Reolysin data. Lowering target to $4.00 due to expected delays in time to marketBiotechnologyDownloadbiotechnology
09-07-2012Diagnocure Inc.TSX:CURPrevistage sales stopped. Progensa future uncertain. Lowering rating to Sell, price target to $0.50BiotechnologyDownloadbiotechnology
08-30-2012Transition Therapeutics Inc.TSX:TTH, Q:TTHIELND005 phase II bipolar disease trial startsBiotechnologyDownloadbiotechnology
08-30-2012PALADIN LABS INC.TSX:PLBUpgrading to Buy from Hold. South African pharma market expected to growBiotechnologyDownloadbiotechnology
08-23-2012Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMFuture strategy of CRME still up in the airBiotechnologyDownloadbiotechnology
08-20-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZSummary of Q2 2012 resultsBiotechnologyDownloadbiotechnology
08-09-2012Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMLowering price target to $0.30 as Brinavess sales appear low. Awaiting strategic updateBiotechnologyDownloadbiotechnology
08-08-2012Medicago Inc.TSX:MDGQ2 2012 results as expectedBiotechnologyDownloadbiotechnology
08-08-2012CRH Medical Corp.TSX:CRHQ2 2012 results sequentially flat. Lowering price target to $1.00BiotechnologyDownloadbiotechnology
08-02-2012Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIQ2 2012 results better than expectedBiotechnologyDownloadbiotechnology
08-02-2012Nuvo Research Inc.TSX:NRIQ2 2012 profit results from US$5.0 million Pliaglis milestoneBiotechnologyDownloadbiotechnology
08-02-2012QLT INC.NASDAQ: QLTI; TSX:QLTQ2 2012 results; Visudyne losing market share. Expenses high until restructuring completeBiotechnologyDownloadbiotechnology
08-02-2012PALADIN LABS INC.TSX:PLBQ2 2012 results show slower growth; H2 2012 expected to be strongBiotechnologyDownloadbiotechnology
08-02-2012Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ2 2012 EPS ($0.13). Patiently waiting for Reolysin dataBiotechnologyDownloadbiotechnology
07-26-2012PALADIN LABS INC.TSX:PLBQ2 2012 PreviewBiotechnologyDownloadbiotechnology
07-24-2012Medicago Inc.TSX:MDGSuccessful production of 10 million pandemic flu vaccine dosesBiotechnologyDownloadbiotechnology
07-24-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZAEZS requests Fast Track designation for Solorel™BiotechnologyDownloadbiotechnology
07-23-2012Nuvo Research Inc.TSX:NRIPennsaid® gets new use patent; generics apply for approvalBiotechnologyDownloadbiotechnology
07-20-2012Medicago Inc.TSX:MDGRevising model as timing of revenues appears at risk. Lowering price target to $0.75BiotechnologyDownloadbiotechnology
07-19-2012PALADIN LABS INC.TSX:PLBUpdate from management affirms our positive outlook. Rating lowered to Hold due to share price appreciationBiotechnologyDownloadbiotechnology
07-18-2012Theratechnologies Inc.TSX:TH; Q:THEREuropean regulators provide reasons for Egrifta application concernsBiotechnologyDownloadbiotechnology
07-12-2012Theratechnologies Inc.TSX:TH; Q:THERQ2 F2012 results slightly ahead of consensusBiotechnologyDownloadbiotechnology
07-11-2012Canadian HealthcareNavigating the Canadian Biotech SpaceBiotechnologyDownloadbiotechnology
07-09-2012QLT INC.NASDAQ: QLTI; TSX:QLTShake-up at QLTI. Sole focus is QLT091001BiotechnologyDownloadbiotechnology
07-09-2012Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMMore workforce reductions; little upside remainsBiotechnologyDownloadbiotechnology
07-03-2012Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMCEO departs; expect strategic update by mid-AugustBiotechnologyDownloadbiotechnology
06-27-2012Theratechnologies Inc.TSX:TH; Q:THERTesamorelin in obese patients results in VAT reductions; no impact on weightBiotechnologyDownloadbiotechnology
06-26-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZFinal Solorel™ phase III resultsBiotechnologyDownloadbiotechnology
06-25-2012Theratechnologies Inc.TSX:TH; Q:THERTesamorelin approvals in Canada and EU unlikely. Lowering rating to Sell from Hold, price target to $0.75BiotechnologyDownloadbiotechnology
06-20-2012Oncolytics Biotech Inc.TSX:ONC; Q:ONCYReolysin safety OK; still awaiting PFS data from first stage of trialBiotechnologyDownloadbiotechnology
06-19-2012Medicago Inc.TSX:MDGU.S. government provides US$400 million in funding for pandemic preparednessBiotechnologyDownloadbiotechnology
06-11-2012Diagnocure Inc.TSX:CURRecap of Q2 F2012 resultsBiotechnologyDownloadbiotechnology
06-05-2012Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIASCO highlights – OGX-427 continues to show promiseBiotechnologyDownloadbiotechnology
06-05-2012QLT INC.NASDAQ: QLTI; TSX:QLTNew Board of Directors electedBiotechnologyDownloadbiotechnology
05-31-2012QLT INC.NASDAQ: QLTI; TSX:QLTQLTI proposes one-time dividend or Dutch auction to return capitalBiotechnologyDownloadbiotechnology
05-29-2012PALADIN LABS INC.TSX:PLBJonathan Goodman returns to PLB as ChairmanBiotechnologyDownloadbiotechnology
05-28-2012Nuvo Research Inc.TSX:NRISynera® licensed to Paladin Labs for Canada; NRI receives up to $8 million loanBiotechnologyDownloadbiotechnology
05-28-2012PALADIN LABS INC.TSX:PLBPLB licenses Synera® from Nuvo Research; provides up to $8 million loanBiotechnologyDownloadbiotechnology
05-25-2012QLT INC.NASDAQ: QLTI; TSX:QLTQLTI defers AGM, highlights product progress, proposes modified Dutch auctionBiotechnologyDownloadbiotechnology
05-23-2012QLT INC.NASDAQ: QLTI; TSX:QLTQLT shareholder aims to modify Board, but no future plans identifiedBiotechnologyDownloadbiotechnology
05-22-2012Diagnocure Inc.TSX:CURPSA testing no longer recommendedBiotechnologyDownloadbiotechnology
05-15-2012Medicago Inc.TSX:MDGQ1 2012 results. High R&D as DARPA contract coming to an endBiotechnologyDownloadbiotechnology
05-14-2012Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMQ1 2012 losses lower than expected. Strategic update expected within 2 monthsBiotechnologyDownloadbiotechnology
05-11-2012YM Biosciences Inc.TSX:YM; AMEX:YMIQ3 F2012 results better than expectedBiotechnologyDownloadbiotechnology
05-10-2012QLT INC.NASDAQ: QLTI; TSX:QLTARVO update expands on efficacy and safety of QLT091001BiotechnologyDownloadbiotechnology
05-10-2012Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ1 2012 EPS ($0.11). Reolysin interim data may be imminentBiotechnologyDownloadbiotechnology
05-09-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ1 2012 results. Product development appears slowBiotechnologyDownloadbiotechnology
05-09-2012Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ3 F2012 results in lineBiotechnologyDownloadbiotechnology
05-07-2012Nuvo Research Inc.TSX:NRIPositive Pliaglis recommendation from German regulatorsBiotechnologyDownloadbiotechnology
05-07-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZAEZS regains perifosine rights; continues with multiple myeloma studyBiotechnologyDownloadbiotechnology
05-04-2012Oncogenex Pharmaceuticals Inc.NASDAQ: OGXINo major surprises in Q1 results. Expect R&D to ramp up in H2; price target lowered to $18.00BiotechnologyDownloadbiotechnology
05-03-2012Nuvo Research Inc.TSX:NRIQ1 2012 results show Pennsaid growth but trends unlikely to continue. Lowering price target to $0.10BiotechnologyDownloadbiotechnology
05-03-2012QLT INC.NASDAQ: QLTI; TSX:QLTQ1 2012 EPS ($0.21); R&D spend high as progressing to phase IIIBiotechnologyDownloadbiotechnology
05-03-2012PALADIN LABS INC.TSX:PLBQ1 2012 beats ‘the Street’. Another record quarterBiotechnologyDownloadbiotechnology
04-26-2012CRH Medical Corp.TSXV:CRMQ1 2012 results continue to show growth. Upgrading to Buy, price target to $1.25BiotechnologyDownloadbiotechnology
04-26-2012PALADIN LABS INC.TSX:PLBQ1 2012 – Expecting an OK quarter but H2 2012 likely to improveBiotechnologyDownloadbiotechnology
04-24-2012CRH Medical Corp.TSXV:CRMRevenues ramping up. Profit improvingBiotechnologyDownloadbiotechnology
04-18-2012Nuvo Research Inc.TSX:NRIA bump in the road for Pliaglis®BiotechnologyDownloadbiotechnology
04-13-2012Theratechnologies Inc.TSX:TH; Q:THERQ1 F2012 results impacted by restructuring costsBiotechnologyDownloadbiotechnology
04-12-2012QLT INC.NASDAQ: QLTI; TSX:QLTEyeing the future: Initiating coverage with Buy rating, $10.00 targetBiotechnologyDownloadbiotechnology
04-11-2012Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMUpgrading to Hold due to price depreciationBiotechnologyDownloadbiotechnology
04-09-2012Nuvo Research Inc.TSX:NRIPennsaid® sales surge on Voltaren® Gel shortages. Price target increased to $0.14BiotechnologyDownloadbiotechnology
04-09-2012Diagnocure Inc.TSX:CURQ1 F2012 results recapBiotechnologyDownloadbiotechnology
04-02-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZPerifosine fails to show survival improvement in colorectal cancer. Lowering rating to Sell, price target to $0.50BiotechnologyDownloadbiotechnology
04-02-2012Oncolytics Biotech Inc.TSX:ONC; Q:ONCY80th patient recruited into head & neck cancer trialBiotechnologyDownloadbiotechnology
03-30-2012Medicago Inc.TSX:MDG2011 financial results essentially in line with our forecastsBiotechnologyDownloadbiotechnology
03-28-2012Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMF2011 results and view post oral vernakalant discontinuation. Price target lowered to $0.60BiotechnologyDownloadbiotechnology
03-28-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZ2011 results benefit from higher revenues. Phase III perifosine results could come in May 2012BiotechnologyDownloadbiotechnology
03-26-2012Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIUpdating estimates post $57.5 million equity offering. Price target lowered to $19.00BiotechnologyDownloadbiotechnology
03-15-2012Oncolytics Biotech Inc.TSX:ONC; Q:ONCY2011 EPS ($0.41). Reolysin data now appears delayed to Q2BiotechnologyDownloadbiotechnology
03-12-2012YM Biosciences Inc.TSX:YM; AMEX:YMIUpdate on YM post equity offering of US$80.5 millionBiotechnologyDownloadbiotechnology
03-09-2012Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIAs the prostate cancer market turns, custirsen development plan evolves. Price target lowered to $24.00BiotechnologyDownloadbiotechnology
03-06-2012Medicago Inc.TSX:MDGMitsubishi collaboration to bring in revenue stream. Price target to $1.25BiotechnologyDownloadbiotechnology
02-27-2012Theratechnologies Inc.TSX:TH; Q:THERQuebec Court authorizes class action suitBiotechnologyDownloadbiotechnology
02-21-2012Nuvo Research Inc.TSX:NRIPliaglis on track for EU and U.S. launches in H2 2012BiotechnologyDownloadbiotechnology
02-21-2012Theratechnologies Inc.TSX:TH; Q:THERTH inks Canadian distribution deal for tesamorelinBiotechnologyDownloadbiotechnology
02-21-2012PALADIN LABS INC.TSX:PLBPLB builds its South African presence. Price target increased to $50.00BiotechnologyDownloadbiotechnology
02-17-2012Oncolytics Biotech Inc.TSX:ONC; Q:ONCYERRATUM – Reolysin interim data coming soon. Price target lowered to $7.50BiotechnologyDownloadbiotechnology
02-16-2012PALADIN LABS INC.TSX:PLBRecord 2011 revenues but future growth forecasts are flat. Price target to $48.00BiotechnologyDownloadbiotechnology
02-15-2012Diagnocure Inc.TSX:CURProgensa™ PCA3 assay receives FDA approvalBiotechnologyDownloadbiotechnology
02-09-2012YM Biosciences Inc.TSX:YM; AMEX:YMIQ2 F2012 results as expected. Competitive JAK landscape examinedBiotechnologyDownloadbiotechnology
02-09-2012PALADIN LABS INC.TSX:PLBQ4 2011 preview: Expecting a strong finish to 2011. Upping price target to $49.00BiotechnologyDownloadbiotechnology
02-08-2012Theratechnologies Inc.TSX:TH; Q:THERF2011 results show low revenue growth; expenses under controlBiotechnologyDownloadbiotechnology
02-02-2012Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIOGX-427 prostate cancer data highly encouragingBiotechnologyDownloadbiotechnology
02-02-2012Nuvo Research Inc.TSX:NRISynera® re-launched in the U.SBiotechnologyDownloadbiotechnology
01-30-2012Diagnocure Inc.TSX:CURSummarizing Q4 F2011 results. Lowering price target to $1.00BiotechnologyDownloadbiotechnology
01-24-2012Æterna Zentaris Inc.Q:AEZS; TSX:AEZAEZS announces another “At the Market” offering of up to $16 millionBiotechnologyDownloadbiotechnology
01-19-2012Medicago Inc.TSX:MDGMDG announces development of a rabies vaccineBiotechnologyDownloadbiotechnology
01-16-2012Medicago Inc.TSX:MDGMDG signs research agreement with CellectisBiotechnologyDownloadbiotechnology
01-04-2012Canadian HealthcareNavigating the Canadian Biotech SpaceBiotechnologyDownloadbiotechnology
12-15-2011Nuvo Research Inc.TSX:NRIU.S. partner plans to spin off pharma businessBiotechnologyDownloadbiotechnology
12-13-2011YM Biosciences Inc.TSX:YM; AMEX:YMIOn the 12th day of Christmas…12 weeks of transfusion independenceBiotechnologyDownloadbiotechnology
12-07-2011Theratechnologies Inc.TSX:THTSX:TH; Q:THERDiscontinuation of COPD program and downsizing to save costs. Lowering price target to $2.50BiotechnologyDownloadbiotechnology
12-05-2011Nuvo Research Inc.TSX:NRIAcquisition of remaining 40% of German subsidiaryBiotechnologyDownloadbiotechnology
12-02-2011Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ1 F2012 results. TTH manages its cash flow. Increasing target to $2.00BiotechnologyDownloadbiotechnology
11-29-2011PALADIN LABS INC.TSX:PLBPLB in-licenses Travelan®BiotechnologyDownloadbiotechnology
11-23-2011Æterna Zentaris Inc.Q:AEZS; TSX:AEZPerifosine licensed to Hikma for the Middle East and North AfricaBiotechnologyDownloadbiotechnology
11-21-2011Transition Therapeutics Inc.TSX:TTH, Q:TTHIUS$5 million private placement to bolster the balance sheet. Lowering target to $1.50BiotechnologyDownloadbiotechnology
11-17-2011YM Biosciences Inc.TSX:YM; AMEX:YMICompetitor JAK1/2 inhibitor approved by the FDABiotechnologyDownloadbiotechnology
11-15-2011Nuvo Research Inc.TSX:NRIPennsaid® samples cease to be distributedBiotechnologyDownloadbiotechnology
11-15-2011Medicago Inc.TSX:MDGQ3 2011 EPS ($0.03). North Carolina facility ramping up for businessBiotechnologyDownloadbiotechnology
11-14-2011Oncolytics Biotech Inc.TSX:ONC; Q:ONCYReolysin shows signs of activityBiotechnologyDownloadbiotechnology
11-12-2011YM Biosciences Inc.TSX:YM; AMEX:YMIQ1 F2012 operational results in line. Lowering target to $4.00 due to lower nimotuzumab forecastsBiotechnologyDownloadbiotechnology
11-10-2011Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMMerck R&D briefing confirms vernakalant development plansBiotechnologyDownloadbiotechnology
11-10-2011Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ3 2011 operational results in line. Waiting for perifosine dataBiotechnologyDownloadbiotechnology
11-10-2011Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ3 2011 EPS ($0.09). Progressing towards first stage phase III resultsBiotechnologyDownloadbiotechnology
11-08-2011Diagnocure Inc.TSX:CURPartner confirms no FDA panel meeting necessary. Could approval be forthcoming?BiotechnologyDownloadbiotechnology
11-07-2011Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMQ3 EPS ($0.12). Looking for an update at Merck’s R&D briefingBiotechnologyDownloadbiotechnology
11-07-2011YM Biosciences Inc.TSX:YM; AMEX:YMILatest CYT387 data supports safety profileBiotechnologyDownloadbiotechnology
11-04-2011Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIQ3 2011 operating expenses low but R&D expected to ramp upBiotechnologyDownloadbiotechnology
11-04-2011Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMVernakalant oral development slows to a crawl. Lowering rating to SellBiotechnologyDownloadbiotechnology
11-04-2011PALADIN LABS INC.TSX:PLBPLB continues its winning ways with a strong Q3BiotechnologyDownloadbiotechnology
11-03-2011Nuvo Research Inc.TSX:NRIQ3 2011 results show slow growthBiotechnologyDownloadbiotechnology
10-27-2011Medicago Inc.TSX:MDGPhilip Morris invests another $22.5 millionBiotechnologyDownloadbiotechnology
10-27-2011PALADIN LABS INC.TSX:PLBPreview of Q3 2011 resultsBiotechnologyDownloadbiotechnology
10-26-2011CRH Medical Corp.TSXV:CRMAnother profitable quarter but growth continues to be slow. Lowering target to $1.00BiotechnologyDownloadbiotechnology
10-17-2011Theratechnologies Inc.TSX:TH; Q:THERQ3 F2011 EPS ($0.07). Slow growth of Egrifta®BiotechnologyDownloadbiotechnology
10-03-2011What Investors Should Look For in a Development-Stage Biotech CompanyBiotechnologyDownloadbiotechnology
10-03-2011PALADIN LABS INC.TSX:PLBPLB forgoes offer for Afexa; earns over $5 million on its investmentBiotechnologyDownloadbiotechnology
09-28-2011Medicago Inc.TSX:MDGLowering price target to $1.00 after $25.0 million equity raiseBiotechnologyDownloadbiotechnology
09-23-2011YM Biosciences Inc.TSX:YM; AMEX:YMIF2011 results reported. Lowering target to $4.50BiotechnologyDownloadbiotechnology
09-22-2011PALADIN LABS INC.TSX:PLBERRATUM: PLB intends to increase bid for AfexaBiotechnologyDownloadbiotechnology
09-20-2011Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ4 F2011 results. Elan decision likely critical to TTH valueBiotechnologyDownloadbiotechnology
09-15-2011Diagnocure Inc.TSX:CURUpdates to CUR model post Q3 F2011 resultsBiotechnologyDownloadbiotechnology
09-14-2011Nuvo Research Inc.TSX:NRIPennsaid® Viscous Solution to be an sNDA filing with FDABiotechnologyDownloadbiotechnology
08-30-2011Diagnocure Inc.TSX:CURProgensa® PCA3 FDA panel meeting delayed. Price target lowered to $1.25BiotechnologyDownloadbiotechnology
08-30-2011Æterna Zentaris.Inc Q:AEZS; TSX:AEZSolorel™ achieves primary endpoint in phase III trialBiotechnologyDownloadbiotechnology
08-30-2011PALADIN LABS INC.TSX:PLBPLB’s Afexa bid trumped by ValeantBiotechnologyDownloadbiotechnology
08-17-2011Diagnocure Inc.TSX:CURProgensa® PCA3 assay approved by Health CanadaBiotechnologyDownloadbiotechnology
08-17-2011PALADIN LABS INC.TSX:PLBPLB to acquire Labopharm for $20.45 million. Increasing rating to Buy, price target to $45.00BiotechnologyDownloadbiotechnology
08-15-2011Medicago Inc.TSX:MDGQ2 2011 EPS ($0.03), operational expenses in line with estimatesBiotechnologyDownloadbiotechnology
08-12-2011PALADIN LABS INC.TSX:PLBQ2 2011 results in line with consensus. Price target increased to $43BiotechnologyDownloadbiotechnology
08-11-2011Nuvo Research Inc.TSX:NRIQ2 2011 results a little light. Lowering rating to Hold; price target to $0.10BiotechnologyDownloadbiotechnology
08-11-2011Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ2 2011 results a little lower than expectedBiotechnologyDownloadbiotechnology
08-10-2011Theratechnologies Inc.TSX:TH; Q:THERUpgrading to Hold due to implied return to price targetBiotechnologyDownloadbiotechnology
08-10-2011PALADIN LABS INC.TSX:PLBNothing to sneeze at – PLB goes hostile on AfexaBiotechnologyDownloadbiotechnology
08-09-2011Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMQ2 EPS ($0.13). Next move belongs to Merck. Lowering target to $6.00BiotechnologyDownloadbiotechnology
08-05-2011Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIQ2 2011 operating costs in line. Lowering target to $28.00 due to minor delays in study timingBiotechnologyDownloadbiotechnology
08-05-2011PALADIN LABS INC.TSX:PLBPreview of Q2 2011 resultsBiotechnologyDownloadbiotechnology
08-04-2011PALADIN LABS INC.TSX:PLBScenario Analysis: Expect positive impact on PLB if PharmaPlan is purchasedBiotechnologyDownloadbiotechnology
08-03-2011CRH Medical Corp.TSXV:CRMSecond straight profitable quarter. Price target decreased to $1.25 due to slower than expected top-line growthBiotechnologyDownloadbiotechnology
07-28-2011Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ2 2011 EPS ($0.10). Heavy R&D spend as phase III trial progressesBiotechnologyDownloadbiotechnology
07-27-2011Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMMerck steps up to acquire vernakalant IV rights from AstellasBiotechnologyDownloadbiotechnology
07-20-2011Nuvo Research Inc.TSX:NRIQ2 Pennsaid prescriptions grew as expectedBiotechnologyDownloadbiotechnology
07-18-2011PALADIN LABS INC.TSX:PLBPLB acquires 14.94% of AfexaBiotechnologyDownloadbiotechnology
07-07-2011Theratechnologies Inc.TSX:TH; Q:THERQ2 F2011 EPS ($0.10). Egrifta sales start slowlyBiotechnologyDownloadbiotechnology
07-06-2011Canadian HealthcareNavigating the Canadian Biotech SpaceBiotechnologyDownloadbiotechnology
07-06-2011Oncolytics Biotech Inc.TSX:ONC; Q:ONCYEncouraging but not overwhelming interim data from phase II lung cancer trialBiotechnologyDownloadbiotechnology
06-30-2011Nuvo Research Inc.TSX:NRIPositive Pennsaid viscous solution phase II resultsBiotechnologyDownloadbiotechnology
06-30-2011Medicago Inc.TSX:MDGEncouraging results from H5N1 (pandemic flu) phase II studyBiotechnologyDownloadbiotechnology
06-29-2011Diagnocure Inc.TSX:CURCUR licences Previstage and sells lab to Signal Genetics for US$13.3 million. Raising price target to $1.50BiotechnologyDownloadbiotechnology
06-15-2011Theratechnologies Inc.TSX:THUpdate on TH. Price target increased to $4.50 but Sell rating maintainedBiotechnologyDownloadbiotechnology
06-09-2011PALADIN LABS INC.TSX:PLBPLB keeping investors alert by investing in drowsinessBiotechnologyDownloadbiotechnology
06-08-2011Oncolytics Biotech Inc.TSX:ONC; Q:ONCYInterim data from phase II lung cancer study highly encouragingBiotechnologyDownloadbiotechnology
06-08-2011Medicago Inc.TSX:MDGPositive results for H1N1 (seasonal flu) phase I studyBiotechnologyDownloadbiotechnology
06-07-2011Diagnocure Inc.TSX:CURQ2 F2011 EPS ($0.04). Lowering target to $1.00BiotechnologyDownloadbiotechnology
06-06-2011YM Biosciences Inc.TSX:YM; AMEX:YMIASCO data supports optimism around CYT387BiotechnologyDownloadbiotechnology
05-31-2011YM Biosciences Inc.TSX:YM; AMEX:YMINorth American nimotuzumab program curtailedBiotechnologyDownloadbiotechnology
05-30-2011Medicago Inc.TSX:MDGQ1 2011 EPS ($0.04) as expected. Awaiting H5N1 phase II resultsBiotechnologyDownloadbiotechnology
05-27-2011Nuvo Research Inc.TSX:NRIQ1 results. Pennsaid reimbursement could have positive impact in H2. Lowering target to $0.15BiotechnologyDownloadbiotechnology
05-27-2011Æterna Zentaris Inc.Q:AEZS; TSX:AEZEvaluation of risks with perifosine phase III colorectal trialBiotechnologyDownloadbiotechnology
05-26-2011PALADIN LABS INC.TSX:PLBShare buyback likely to favourably impact share priceBiotechnologyDownloadbiotechnology
05-26-2011PALADIN LABS INC.TSX:PLBQ1 2011 EBITDA $17.3 million; expect profit-taking on these results. Lowering target to $41.00BiotechnologyDownloadbiotechnology
05-24-2011PALADIN LABS INC.TSX:PLBQ1 preview; expect another strong quarter. Raising price target to $42.00BiotechnologyDownloadbiotechnology
05-19-2011YM Biosciences Inc.TSX:YM; AMEX:YMIASCO abstract previews limited data for upcoming conferenceBiotechnologyDownloadbiotechnology
05-12-2011Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ1 2011 EPS ($0.06); Reolysin studies progressingBiotechnologyDownloadbiotechnology
05-12-2011YM Biosciences Inc.TSX:YM; AMEX:YMIQ3 F2011 EPS ($0.06). Increasing price target to $5.00BiotechnologyDownloadbiotechnology
05-12-2011Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ3 F2011 EPS ($0.13). No news on ELND005. Early stage compounds progressing slowlyBiotechnologyDownloadbiotechnology
05-11-2011Oncolytics Biotech Inc.TSX:ONC; Q:ONCYPrepping Reolysin for marketBiotechnologyDownloadbiotechnology
05-10-2011Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIQ1 2011 EPS ($0.31). Modifications to SATURN trial to keep it relevantBiotechnologyDownloadbiotechnology
05-04-2011YM Biosciences Inc.TSX:YM; AMEX:YMILatest activity in the JAK inhibitor worldBiotechnologyDownloadbiotechnology
04-28-2011CRH Medical Corp.TSXV:CRMCRM announces preliminary profitable Q1. Poised for growth. Lowering target to $1.75BiotechnologyDownloadbiotechnology
04-26-2011CRH Medical Corp.NYSE MKT:CRHM, TSX:CRH2010 EPS ($0.03). Company expected to reach profitability in the near-termBiotechnologyDownloadbiotechnology
04-21-2011Medicago Inc.TSX:MDGTobacco and vaccines – “There’s an App for that”™BiotechnologyDownloadbiotechnology
04-18-2011Nuvo Research Inc.TSX:NRIEasing the pain: Acquisition of ZARS PharmaBiotechnologyDownloadbiotechnology
04-18-2011YM Biosciences Inc.TSX:YM; AMEX:YMILatest anemia data appear promisingBiotechnologyDownloadbiotechnology
04-13-2011Theratechnologies Inc.TSX:THQ1 F2011 EPS ($0.10). Egrifta™ sales to be reported in fiscal Q2BiotechnologyDownloadbiotechnology
04-04-2011YM Biosciences Inc.TSX:YM; AMEX:YMIUpdate on myelofibrosis from principal investigator in CYT387 trialBiotechnologyDownloadbiotechnology
03-23-2011Æterna Zentaris Inc.Q:AEZS; TSX:AEZ2010 EPS ($0.31) better than expected. Raising target to $2.50BiotechnologyDownloadbiotechnology
03-17-2011Oncolytics Biotech Inc.TSX:ONC; Q:ONCY2010 EPS ($0.32); expect newsworthy 2011BiotechnologyDownloadbiotechnology
03-15-2011Diagnocure Inc.TSX:CURQ1 F2011 results in line. Upgrading to Hold based on implied returnBiotechnologyDownloadbiotechnology
03-14-2011Oncogenex Pharmaceuticals Inc.NASDAQ: OGXI2010 EPS ($1.79); better than expected. Increasing target to $30.00BiotechnologyDownloadbiotechnology
03-14-2011Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMClinical development slowed. Price target lowered to $7.00BiotechnologyDownloadbiotechnology
03-14-2011Theratechnologies Inc.TSX:THCancellation of equity offering results in price target increase to $4.00BiotechnologyDownloadbiotechnology
03-01-2011Nuvo Research Inc.TSX:NRIQ4 2011 results show slow growth. 2012 off to a good startBiotechnologyDownloadbiotechnology
02-28-2011PALADIN LABS INC.TSX:PLBResuming coverage: Price target increased to $37.00BiotechnologyDownloadbiotechnology
02-25-2011Nuvo Research Inc.TSX:NRI2010 EPS ($0.02). Pennsaid sales affected by lack of reimbursement. Target lowered to $0.30BiotechnologyDownloadbiotechnology
02-23-2011Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMEU regulators recommend additional contraindication for Brinavess™. Price target lowered to $7.50BiotechnologyDownloadbiotechnology
02-23-2011Theratechnologies Inc.TSX:THTH files secondary offering. Second indication for tesamorelin to be COPD muscle wasting. Target lowered to $3.50BiotechnologyDownloadbiotechnology
02-10-2011Theratechnologies Inc.TSX:THF2010 EPS $0.15; lowering price target to $4.50BiotechnologyDownloadbiotechnology
02-10-2011YM Biosciences Inc.TSX:YM; AMEX:YMIQ2 F2011 EPS ($0.10); an eventful year aheadBiotechnologyDownloadbiotechnology
02-09-2011YM Biosciences Inc.TSX:YM; AMEX:YMIUpgrading from Hold to BuyBiotechnologyDownloadbiotechnology
02-08-2011Nuvo Research Inc.TSX:NRIInitiating coverage: Buy, Speculative Risk Rating, $0.35 price targetBiotechnologyDownloadbiotechnology
02-08-2011Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ2 F2011 EPS $1.05 due to recognition of Elan paymentsBiotechnologyDownloadbiotechnology
02-03-2011Diagnocure Inc.TSX:CURF2010 results as expectedBiotechnologyDownloadbiotechnology
02-02-2011PALADIN LABS INC.TSX:PLBA little pain relief: Acquisition of Tempra, divestiture of ISA sharesBiotechnologyDownloadbiotechnology
01-20-2011Transition Therapeutics Inc.TSX:TTH, Q:TTHIWith modified Elan agreement, price target lowered to $2.50BiotechnologyDownloadbiotechnology
01-19-2011YM Biosciences Inc.TSX:YM; AMEX:YMINimotuzumab fails to improve PFS in phase II gastric cancer studyBiotechnologyDownloadbiotechnology
01-18-2011PALADIN LABS INC.TSX:PLBRaising price target to $35.00 due to rolling forward estimatesBiotechnologyDownloadbiotechnology
01-05-2011Canadian HealthcareNavigating the Canadian Biotech SpaceBiotechnologyDownloadbiotechnology
01-04-2011YM Biosciences Inc.TSX:YM; AMEX:YMIResuming coverage after equity raise. Target upped to $3.50BiotechnologyDownloadbiotechnology
12-23-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCYRaising price target to $8.00 due to rolling forward valuationBiotechnologyDownloadbiotechnology
12-23-2010Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMIncreasing price target to $8.50 due to rolling forward valuationBiotechnologyDownloadbiotechnology
12-23-2010CRH Medical Corp.TSXV:CRMRaising price target to $2.00 due to rolling forward valuationBiotechnologyDownloadbiotechnology
12-22-2010Theratechnologies Inc.TSX:THTweaking model to reflect milestone received in F2010BiotechnologyDownloadbiotechnology
12-20-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZSolorel™ gets green light for continued testingBiotechnologyDownloadbiotechnology
12-16-2010PALADIN LABS INC.TSX:PLBThe “Bank of Paladin” makes another investmentBiotechnologyDownloadbiotechnology
12-09-2010Theratechnologies Inc.TSX:THEgrifta licensing deal helps set the stage for the futureBiotechnologyDownloadbiotechnology
12-09-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHIDowngrading to Hold, price target lowered to $3.50BiotechnologyDownloadbiotechnology
11-25-2010YM Biosciences Inc.TSX:YM; AMEX:YMICYT387 – Preview of ASH conferenceBiotechnologyDownloadbiotechnology
11-18-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCYResuming coverage post capital raise. Raising price target to $6.00BiotechnologyDownloadbiotechnology
11-18-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZAEZS-108 phase II endometrial cancer data warrants further studyBiotechnologyDownloadbiotechnology
11-18-2010YM Biosciences Inc.TSX:YM; AMEX:YMIExpansion of CYT387 phase I/II trial to determine appropriate dosingBiotechnologyDownloadbiotechnology
11-15-2010Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMQ3 2010 EPS $0.37. Holding for an FDA decision on ACT 5BiotechnologyDownloadbiotechnology
11-11-2010Theratechnologies Inc.TSX:THA day to remember: FDA approves Egrifta™. Lowering rating to Sell, price target to $4.50BiotechnologyDownloadbiotechnology
11-11-2010YM Biosciences Inc.TSX:YM; AMEX:YMIQ1 F2011 EPS ($0.09); in line with our estimateBiotechnologyDownloadbiotechnology
11-11-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ1 F2011 EPS ($0.19); lowering target to $4.50BiotechnologyDownloadbiotechnology
11-10-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ3 2010 EPS ($0.12). No surprisesBiotechnologyDownloadbiotechnology
11-04-2010Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIQ3 2010 EPS ($1.07); includes $4.0 million restructuring chargeBiotechnologyDownloadbiotechnology
11-04-2010PALADIN LABS INC.TSX:PLBQ3 2010 results: Strong EBITDA on lower than expected costsBiotechnologyDownloadbiotechnology
11-02-2010CRH Medical Corp.TSXV:CRMCRM to focus exclusively on direct sales to gastroenterologistsBiotechnologyDownloadbiotechnology
10-29-2010CRH Medical Corp.TSXV:CRMQ3 2010 EPS (0.005); on the verge of break-evenBiotechnologyDownloadbiotechnology
10-28-2010PALADIN LABS INC.TSX:PLBPreview of Q3 resultsBiotechnologyDownloadbiotechnology
10-25-2010Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMA shocking event. Advise caution in advance of FDA feedbackBiotechnologyDownloadbiotechnology
10-19-2010Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIOGXI raises $50 million in public financing. Target price lowered to $25.00BiotechnologyDownloadbiotechnology
10-14-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCYPossibility of a Reolysin partnering deal sooner than later. Increasing price target to $5.50BiotechnologyDownloadbiotechnology
10-14-2010PALADIN LABS INC.TSX:PLBPLB adds pain development-stage products to pipelineBiotechnologyDownloadbiotechnology
10-13-2010Theratechnologies Inc.TSX:THQ3 F2010 EPS (0.05); FDA decision expected near-termBiotechnologyDownloadbiotechnology
09-30-2010Oncogenex Pharmaceuticals Inc.NASDAQ: OGXISYNERGY study starts. OGXI well positioned for the futureBiotechnologyDownloadbiotechnology
09-28-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHIF2010 EPS ($0.83); in line with estimateBiotechnologyDownloadbiotechnology
09-24-2010YM Biosciences Inc.TSX:YM; AMEX:YMIF2010 EPS ($0.33); affected by intangible asset write-offsDownload
09-22-2010Diagnocure Inc.TSX:CURProgensa™ submitted for FDA approvalBiotechnologyDownloadbiotechnology
09-17-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHITT-223 fails in phase II. Lowering price target to $6.00BiotechnologyDownloadbiotechnology
09-14-2010Diagnocure Inc.TSX:CURQ3 results review. Downgrading to SellBiotechnologyDownloadbiotechnology
09-09-2010YM Biosciences Inc.TSX:YM; AMEX:YMIUpdate on JAK2 inhibitors – what CYT387 is up against. Increasing price target to $2.25 due to rolling forward estimatesBiotechnologyDownloadbiotechnology
09-09-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHIPotential Alzheimer’s drug competitors and possible TTH partnersBiotechnologyDownloadbiotechnology
09-07-2010Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMUpdated view post Brinavess™ approvalBiotechnologyDownloadbiotechnology
08-16-2010Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMUpdate to CRME financials. No change to our viewBiotechnologyDownloadbiotechnology
08-13-2010CRH Medical Corp.TSXV:CRMQ2 results weaker than expected. Lowering target to $1.75BiotechnologyDownloadbiotechnology
08-12-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ2 2010 EPS ($0.06). Price target increased to $1.50BiotechnologyDownloadbiotechnology
08-11-2010Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMPhase III oral vernakalant program delayedBiotechnologyDownloadbiotechnology
08-10-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHINo new news post the ELND005 conference call. Reducing price target to $4.50BiotechnologyDownloadbiotechnology
08-09-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHIELND005 will be taken to phase IIIBiotechnologyDownloadbiotechnology
08-05-2010Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIQ2 2010 EPS $0.02. Focus shifting to OGX-427BiotechnologyDownloadbiotechnology
08-05-2010YM Biosciences Inc.TSX:YM; AMEX:YMICYT387 phase I dose escalation complete. Phase II expandedBiotechnologyDownloadbiotechnology
08-05-2010PALADIN LABS INC.TSX:PLBQ2 results impress. Upgrading to Buy, price target to $31.00BiotechnologyDownloadbiotechnology
08-03-2010Diagnocure Inc.TSX:CURNew York State lab permit likely more important for future tests than PrevistageBiotechnologyDownloadbiotechnology
07-29-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ2 2010 EPS ($0.07); in line with estimatesBiotechnologyDownloadbiotechnology
07-29-2010PALADIN LABS INC.TSX:PLBPreview of upcoming Q2 resultsBiotechnologyDownloadbiotechnology
07-08-2010Theratechnologies Inc.TSX:THQ2 F2010 EPS (0.08). Waiting for FDA decisionBiotechnologyDownloadbiotechnology
07-05-2010Canadian HealthcareNavigating the Canadian Biotech SpaceBiotechnologyDownloadbiotechnology
06-25-2010Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMPositive CHMP opinion received for Brinavess™BiotechnologyDownloadbiotechnology
06-24-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHITTH fairly valued if you assume ELND005 will fail; otherwise, cheap. Upgrading to BuyBiotechnologyDownloadbiotechnology
06-23-2010Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIMinor model revisions due to $3 million tax recoveryBiotechnologyDownloadbiotechnology
06-21-2010Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIOGX-011 phase III starts on time. Reiterate Buy ratingBiotechnologyDownloadbiotechnology
06-16-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZAnother round of financing; if warrants are exercised it may be enough. Raising rating to HoldBiotechnologyDownloadbiotechnology
06-15-2010YM Biosciences Inc.TSX:YM; AMEX:YMIInitiating coverage of YM: Looking out for nimoBiotechnologyDownloadbiotechnology
06-10-2010Diagnocure Inc.TSX:CURQ2 F2010 EPS ($0.05); minimal revenue growth but expenses under controlBiotechnologyDownloadbiotechnology
06-08-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCYUpdated Reolysin phase I/II head & neck cancer data support previous findingsBiotechnologyDownloadbiotechnology
05-28-2010Theratechnologies Inc.TSX:THPositive panel meeting bodes well for final FDA decision. Upgrading to HoldBiotechnologyDownloadbiotechnology
05-25-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCYEnrollment opened in Reolysin phase III head and neck cancer trialBiotechnologyDownloadbiotechnology
05-25-2010Theratechnologies Inc.TSX:THTesamorelin briefing package released by FDABiotechnologyDownloadbiotechnology
05-21-2010ASCO 2010 – Abstracts from AEZS, ONC and OGXIBiotechnologyDownloadbiotechnology
05-20-2010Theratechnologies Inc.TSX:THExpectations for tesamorelin (Egrifta™) briefing packageBiotechnologyDownloadbiotechnology
05-18-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCYEncouraging results from early-stage trial on Reolysin plus radiotherapyBiotechnologyDownloadbiotechnology
05-17-2010Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMAVRO data look good. Increasing price target to $7.00BiotechnologyDownloadbiotechnology
05-13-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ1 2010 EPS ($0.09). Raising target to $1.25BiotechnologyDownloadbiotechnology
05-12-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ1 2010 EPS ($0.07)BiotechnologyDownloadbiotechnology
05-11-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ3 F2010 EPS ($0.13). Waiting for ELND005 phase II resultsBiotechnologyDownloadbiotechnology
05-06-2010Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIQ1 2010 EPS ($0.48). OGX-011 development on scheduleBiotechnologyDownloadbiotechnology
05-06-2010PALADIN LABS INC.TSX:PLBA solid start to the year. Increasing price target to $28.00BiotechnologyDownloadbiotechnology
04-29-2010CRH Medical Corp.TSXV:CRMQ1 2010 EPS ($0.01). No surprisesDownload
04-28-2010CRH Medical Corp.TSXV:CRM2009 EPS ($0.05). Product sales growing but center sales stagnantBiotechnologyDownloadbiotechnology
04-16-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZAEZS capitalizes on stock gains to raise $15 million. Raising price target to $1.00BiotechnologyDownloadbiotechnology
04-15-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZEuropean regulators confirm one phase III multiple myeloma perifosine study sufficientBiotechnologyDownloadbiotechnology
04-13-2010ASCO 2010 – Presentations on Canadian Company ProductsBiotechnologyDownloadbiotechnology
04-07-2010PALADIN LABS INC.TSX:PLBSeasonique® approved; another product in the stableBiotechnologyDownloadbiotechnology
03-30-2010Oncogenex Pharmaceuticals Inc.NASDAQ: OGXIInitiating coverage of OGXI: Enhancing chemotherapy by targeting clusterinBiotechnologyDownloadbiotechnology
03-30-2010Diagnocure Inc.TSX:CURMyriad human gene patents invalidated; highlights risk potential for CURBiotechnologyDownloadbiotechnology
03-24-2010Theratechnologies Inc.TSX:THQ1 F2010 EPS ($0.07); in line with estimatesBiotechnologyDownloadbiotechnology
03-24-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZ2009 EPS ($0.43). Benefitting from one-time adjustmentsBiotechnologyDownloadbiotechnology
03-18-2010Diagnocure Inc.TSX:CURQ1 F2010 EPS ($0.09), lower than expected mainly due to restructuring chargesBiotechnologyDownloadbiotechnology
03-17-2010Theratechnologies Inc.TSX:THDowngrading shares from Buy to Sell due to share price appreciationBiotechnologyDownloadbiotechnology
03-17-2010PALADIN LABS INC.TSX:PLBGetting to Jo’burg before the World Cup. Price target increased to $23.50BiotechnologyDownloadbiotechnology
03-09-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCY2009 EPS ($0.33), lower than expected due to R&D spendBiotechnologyDownloadbiotechnology
03-09-2010PALADIN LABS INC.TSX:PLBInitiating coverage of PLB: The tortoise could win the raceBiotechnologyDownloadbiotechnology
03-09-2010PALADIN LABS INC.TSX:PLBInitiating coverage of PLB: The tortoise could win the raceBiotechnologyDownloadbiotechnology
03-03-2010CRH Medical Corp.TSXV:CRMDowngrading shares to Hold based on share price appreciationBiotechnologyDownloadbiotechnology
03-03-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHILicensing and collaboration deal to develop Lilly preclinical diabetes drugBiotechnologyDownloadbiotechnology
02-25-2010Theratechnologies Inc.TSX:THFDA Advisory Committee meeting May 27, 2010BiotechnologyDownloadbiotechnology
02-24-2010Canadian HealthcareNavigating the Canadian Biotech SpaceBiotechnologyDownloadbiotechnology
02-17-2010CRH Medical Corp.TSXV:CRMChina deal adds to distribution networkBiotechnologyDownloadbiotechnology
02-16-2010Oncolytics Biotech Inc.TSX:ONC; Q:ONCYA step in the right direction. UK regulators approve start of phase III Reolysin studyBiotechnologyDownloadbiotechnology
02-16-2010Diagnocure Inc.TSX:CURCUR restructuring aimed at extending cash runwayBiotechnologyDownloadbiotechnology
02-11-2010Theratechnologies Inc.TSX:THF2009 EPS ($0.25); in line with estimatesBiotechnologyDownloadbiotechnology
02-11-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ2 F2010 results mostly in line with estimatesBiotechnologyDownloadbiotechnology
02-03-2010Theratechnologies Inc.TSX:THEU deal for tesamorelin. Price target upped to $6.00BiotechnologyDownloadbiotechnology
02-02-2010Theratechnologies Inc.TSX:THHow to obtain Egrifta™ in the U.SBiotechnologyDownloadbiotechnology
02-02-2010Diagnocure Inc.TSX:CURUpdate of financial model post year-end results. No change to our viewBiotechnologyDownloadbiotechnology
02-01-2010Theratechnologies Inc.TSX:THUpdate on TH. Lowering price target from $5.50 to $5.00 but reiterate Buy ratingBiotechnologyDownloadbiotechnology
01-25-2010Transition Therapeutics Inc.TSX:TTH, Q:TTHIPhase II TT-223 monotherapy data encouraging, but mixed. Target lowered to $9.00 (from $9.50)BiotechnologyDownloadbiotechnology
01-15-2010Diagnocure Inc.TSX:CURF2009 results as expectedBiotechnologyDownloadbiotechnology
01-05-2010Æterna Zentaris Inc.Q:AEZS; TSX:AEZHighly encouraging perifosine colon cancer phase II dataBiotechnologyDownloadbiotechnology
12-17-2009Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMVernakalant IV comparator trial meets primary endpointBiotechnologyDownloadbiotechnology
12-15-2009Transition Therapeutics Inc.TSX:TTH, Q:TTHIELND005 safety questioned. Lowering rating to Hold and target to $9.50BiotechnologyDownloadbiotechnology
12-14-2009Oncolytics Biotech Inc.TSX:ONC; Q:ONCYUpgrading to Buy Rating. Re-instituting research coverageBiotechnologyDownloadbiotechnology
12-07-2009Æterna Zentaris Inc.Q:AEZS; TSX:AEZCetrorelix development dealt a likely fatal blow. Downgrading AEZS to SellBiotechnologyDownloadbiotechnology
12-02-2009Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMVernakalant IV comparator trial results expected soonBiotechnologyDownloadbiotechnology
12-01-2009Diagnocure Inc.TSX:CURMolecular Diagnostics – Aiming for better cancer predictabilityBiotechnologyDownloadbiotechnology
12-01-2009Diagnocure Inc.TSX:CURInitiating coverage of CUR: Aiming for better cancer predictabilityBiotechnologyDownloadbiotechnology
12-01-2009CRH Medical Corp.TSXV:CRMQ3 2009 EPS (US$0.01), in line with our estimatesBiotechnologyDownloadbiotechnology
11-17-2009Æterna Zentaris Inc.Q:AEZS; TSX:AEZScenario analysis on second set of cetrorelix BPH phase III dataBiotechnologyDownloadbiotechnology
11-11-2009Æterna Zentaris Inc.Q:AEZS; TSX:AEZQ3 2009 EPS ($0.19), in line with our estimateBiotechnologyDownloadbiotechnology
11-10-2009Transition Therapeutics Inc.TSX:TTH, Q:TTHIQ1 F2010 EPS ($0.24). Waiting for decision on phase III Alzheimer’s programBiotechnologyDownloadbiotechnology
11-09-2009Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMQ3 2009 EPS ($ 0.01). Higher than expected R&DBiotechnologyDownloadbiotechnology
11-05-2009Oncolytics Biotech Inc.TSX:ONC; Q:ONCYQ3 2009 EPS ($ 0.05); better than expected due to lower R&DBiotechnologyDownloadbiotechnology
11-05-2009Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMRaising target and upgrading to Hold based on implied return and share consolidationDownload
11-05-2009Theratechnologies Inc.TSX:THTesamorelin to be reviewed by FDA Advisory CommitteeBiotechnologyDownloadbiotechnology
09-28-2009Initiating Coverage of Six Biotech CompaniesBiotechnologyDownloadbiotechnology
03-17-2009Cardiome Pharma Corp.NASDAQ:CRME; TSX:COMIncreasing price target to US$6.50 due to model adjustments related to conversion to US GAAPBiotechnologyDownloadbiotechnology